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Cyanobacteria (blue-green algae) are known to produce a diverse repertoire of
biologically active secondary metabolites. When associated with so-called harmful algal
blooms, particularly in freshwater systems, a number of these metabolites have been
associated - as toxins, or commonly cyanotoxins - with human and animal health
concerns. In addition to the known water-soluble toxins from these genera (i.e.
microcystins, cylindrospermopsin, and saxitoxins), our studies have shown that there are
metabolites within the lipophilic extracts of these strains that inhibit vertebrate
development in zebrafish embryos. Following these studies, the zebrafish embryo model
was implemented in the bioassay-guided purification of four isolates of cyanobacterial
harmful algal blooms, namely Aphanizomenon, two isolates of Cylindrospermopsis, and
Microcystis, in order to identify and chemically characterize the bioactive lipophilic
metabolites in these isolates.

vi

We have recently isolated a group of polymethoxy-1-alkenes (PMAs), as potential
toxins, based on the bioactivity observed in the zebrafish embryos. Although PMAs have
been previously isolated from diverse cyanobacteria, they have not previously been
associated with relevant toxicity. These compounds seem to be widespread across the
different genera of cyanobacteria, and, according to our studies, suggested to be derived
from the polyketide biosynthetic pathway which is a common synthetic route for
cyanobacterial and other algal toxins. Thus, it can be argued that these metabolites are
perhaps important contributors to the toxicity of cyanobacterial blooms. In addition to the
PMAs, a set of bioactive glycosidic carotenoids were also isolated because of their
inhibition of zebrafish embryonic development. These pigmented organic molecules are
found in many photosynthetic organisms, including cyanobacteria, and they have been
largely associated with the prevention of photooxidative damage. This is the first
indication of these compounds as toxic metabolites and the hypothesized mode of action
is via their biotransformation to retinoids, some of which are known to be teratogenic.
Additional fractions within all four isolates have been shown to contain other
uncharacterized lipophilic toxic metabolites. This apparent repertoire of lipophilic
compounds may contribute to the toxicity of these cyanobacterial harmful algal blooms,
which were previously attributed primarily to the presence of the known water-soluble
toxins.
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CHAPTER 1
INTRODUCTION

1

1.1. Cyanobacteria Harmful Algal Blooms
Cyanobacteria, despite being commonly referred to as ‘blue-green algae’, are
prokaryotic photosynthetic bacteria that are ubiquitous in nature with fossil records
dating back more than 3 billion years being one of the oldest life forms on earth.
Cyanobacteria are natural inhabitants of rocks, soil, and all water sources, where they can
occur as free-living planktonic cells or form symbiotic phototrophic biofilm. The surface
waters of both marine and freshwater systems, tends to host the growth of cyanobacteria
whenever the conditions of light, temperature, and nutrients (nitrogen and phosphorus)
are conducive, where they can aggregate to form visible masses known as “blooms”,
primarily observed during the hot summer months. In addition to forming these “surface
scum” in freshwater and brackish water reservoirs, cyanobacteria can also form “dense
benthic mats” in marine and freshwater reservoirs. These blooms are then called “harmful
algal blooms” (HAB; more specifically cyanoHABs) when they are associated with the
production of toxic secondary metabolites which causes serious health problems in
humans and animals (Paerl et al., 2011).
Some of the most commonly occurring cyanobacterial blooms in freshwater
sources belong to genera such as Anabaena, Aphanizomenon, Cylindrospermopsis,
Nodularia, Microcystis, Plantothrix (Oscillatoria), and Plectonema (Lyngbya). These
cyanoHABs produce many different toxins that cause various health effects ranging from
mild skin irritations to more severe neurotoxicological effects and even death. Exposure
routes to these toxins include swimming or other recreational activities in contaminated
water sources, ingestion of contaminated drinking water, or consumption of foods in
which there has been bioaccumulation of the toxins. As a result of the large amounts of
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nutrients (nitrates and phosphates) being released into freshwater systems by various
anthropogenic activities, there has been an increase in the eutrophication and
hypertrophication of these systems. In addition, it is thought that with the changing of the
global climate (increasing atmospheric CO2 and temperature) the conditions are more
favorable to the growth and proliferation of these HABs (Paerl et al., 2011). As such
these cyanoHABs are a major environmental and health problem around the world,
particularly because of the production of various toxins including the known commonly
studied toxins and those toxins which still remain unknown.

1.2. Cyanobacterial Secondary Metabolites (or Cyanobacterial Toxins)
As a result of the long evolutionary history of cyanobacteria, they have developed
morphological, physiological, and ecological adaptability to geochemical and ecological
changes in their environment. Cyanobacteria produce various types of secondary
metabolites (usually genera-, species-, and strain-specific) which allow them to persist
under harsh conditions such as high herbivory and extreme nutrient and light conditions
(Yadav et al., 2011). These secondary metabolites can be classified into groups according
to the functions of the compounds, having both positive and negative effects, such as
antiviral compounds, grazer/feeding deterrents, antimicrobial compounds, anticancer
compounds, protease inhibitors, photoprotective compounds, and cyanotoxic compounds
(Yadav et al., 2011). Cyanobacterial toxins are referred to as such because of the negative
health effects that are associated with their exposure to humans and animals.
Table 1.1 provides a list of the various known cyanobacterial toxins according to
their chemical composition and also includes their toxicological classification, and the
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genera from which they are produced. The toxicological classification is also included for
each of the cyanotoxins based on their action on principal target organs and includes
hepatotoxins, neurotoxins, dermatotoxins, and endotoxins. Even though these toxins
might have the same target organ, they are structurally different and as such have
different mechanism of action with some toxins producing the similar effects (e.g.,
neurotoxins causing respiratory paralysis).

4

Table 1. 1: Cyanobacterial Toxins, Their Toxicological Classification, Toxin Producing Genera, and Mode of Action

Class of Cmpds Toxin/Toxin Group
Cyclic Peptides Microcystins

Alkaloids

Others

T.C.
Hepatotoxins

Toxin-producing genera
Microcystis, Anabaena,
Oscillatoria, Nostoc,
Anabaenopsis, Planktothrix, others
Nodularia

Nodularins

Hepatotoxins

Anatoxin-a,
Homoanatoxin-a

Neurotoxins

Anatoxin-a(s)

Neurotoxins

Saxitoxins

Neurotoxins

Cylindrospermopsin

Hepatotoxins

Lyngbyatoxin

Dermatoxin

Aphanizomenon, Anabaena,
Lyngbya, Cylindrospermopsis
Anabaena, Aphanizomenon,
Cylindrospermopsis, Raphidiopsis
Lyngbya

Aplysiatoxin

Dermatoxin

Lyngbya, Oscillatoria

β-methylamino-ʟalanine (BMAA)

Neurotoxins

Nostoc, Fischerella, Symploca,
Synechococcus, Trichodesmium
and many others

Lipopolysaccharides

Endotoxins

Microcystis, Oscillatoria

Anabaena, Aphanizomenon,
Oscillatoria, Microcystis,
Phormidium, Cylindrospermum,
Raphidiopsis,
Anabaena

Note: Updated from Codd et al, 1999; Stewart et al, 2006.
T.C. – toxicological classification
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Mode of Action
Inhibits serine/threonine
protein phosphatases 1 and 2A
Inhibits serine/threonine
protein phosphatases 1 and 2A
Neuromuscular blocking
agent
Inhibits neurotransmission
Blocks sodium channels in
nerve cells
Inhibits protein synthesis
Inflammatory and tumor
promoting via activation of
protein kinase C
Activation of protein kinase C
Glutamate receptor agonist,
induction of oxidative stress,
and other unknown
mechanisms
Stimulation of inflammatory
responses

1.2.1. Hepatotoxic Cyclic Peptides
Microcystin (MCYST) is one of the most commonly studied cyanotoxins and is a
part of a family of cyclic heptapeptides with over 70 different variants currently isolated
from various cyanobacterial strains (Yadav et al., 2011). These variants of MCYST are
usually seen by the different amino acids at the R1 and R2 positions (Figure 1.1), with the
most commonly isolated MCSYTs being microcystin-LR, -RR, and -YR in the R1 and R2
positions respectively, where L is leucine, R is arginine, and Y is tyrosine (Izaguirre et
al., 2007, Jungblut & Neilan, 2006). Microcystin was first isolated from the freshwater
cyanobacterium Microcystis aeruginosa and has subsequently been isolated from other
cyanobacterial genera including Anabaena, Oscillatoria, Nostoc, Anabaenopsis,
Planktothrix, and others (Prieto et al., 2006; Izaguirre et al., 2007; Sangolkar et al., 2006;
Carmichael, 1992).
Microcystins are potently toxic, and exposure to these toxins has been associated
with animal and human poisoning, and in severe cases, has led to death in vertebrate
animals and humans (Wiegand et al., 2005). They are known to cause liver damage
through the inhibition of type 1 and 2A serine/threonine protein phosphatases, which
leads to excessive phosphorylation of cytoskeleton filaments (Dai et al., 2007). They also
promote the growth of tumors in the liver and colon, and can produce allergic and
gastrointestinal reactions through long term exposure to low levels (Dai et al., 2007).
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Figure 1. 1: General structure of microcystin showing the variable R-groups (R1, R2).

Nodularins (NOD) are another class of nonribosomal hepatotoxic cyclic peptides
that are similar in structure to that of microcystins with less structural variation within the
family, and slightly higher water solubility (Figure 1.2). Nodularin is produced by the
cyanobacterium, Nodularia spumigena, which is commonly found as blooms in the
brackish waters of the Baltic Sea. Nodularins are closetly related to MCYSTs (possessing
the same Adda moiety) and also act by inhibiting the serine/threonine protein
phosphatases type 1 and type 2A (Ohta et al., 1994, Pflugmacher et al., 1998). Nodularin
producing N. spumigena has been linked to deaths of both domestic and wild animals in
regions such as Australia, New Zealand, and the Baltic Sea (Moffitt and Neilan 2004).

Figure 1. 2: Structure of nodularin
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1.2.2. Neurotoxic Alkaloids
Anatoxin-a (ATX) along with its methylene homologue, homoanatoxin-a (Figure
1.3) are neurotoxic alkaloids that are commonly found in the cyanobacterial genera,
Anabaena and Oscillatoria and have been frequently implicated in the poisoning of birds
and mammals (Stewart et al., 2008). Anatoxin-a is a potent nicotinic agonist for the
acetylcholine receptor, acting as a postsynaptic, depolarizing, neuromuscular blocking
agent (James et al., 1997). Exposure to ATX can cause paralysis of the peripheral skeletal
and respiratory muscles, tremors, convulsions, and death (Rogers et al., 2005).

Figure 1. 3: Structure of anatoxin-a (left) and homoanatoxin-a (right)

Anatoxin-a(s) (ATS), (s) for salivation, is a naturally occurring organophosphate
that is associated with the cyanobacteria Anabaena flos-aquae. Despite its name, ATS is
a phosphate ester of a cyclic N-hydroxyguanidine and is therefore unrelated to ATX
(Figure 1.4). The neurotoxic effects associated with ATS are caused by the irreversible
inhibition of acetylcholinesterase, preventing neurotransmission (Devic et al., 2002). The
symptoms associated with this toxin include hypersalivation, ataxia, diarrhea, tremors,
dyspnea, and cyanosis. It is also responsible for the intoxication of domestic animals
(Dittmann and Wiegand, 2006).
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Figure 1. 4: Structure of anatoxin-a(s)

Saxitoxin (STX) is a water-soluble neurotoxic alkaloid (Figure 1.5) that along with
its analogues, are classified as paralytic shellfish toxins (PSTs) as a result of their
involvement in paralytic shellfish poisoning (PSP). There are currently over 20 structural
variants of the toxin and they are classified as non-sulfated, singly-sulfated, doubly
sulfated, and decarbamoylated, and possessing varying degrees of toxicity. Saxitoxins
can be found in both marine (produced by dinoflagellates) and freshwaters (produced by
cyanobacteria) being produced by organisms belonging to two different kingdoms. In
freshwater, STXs have been isolated from the cyanobacteria Cylindrosermopsis,
Anabaena, Aphanizomenon, Lyngbya, and Plantothrix and in marine environments from
the dinoflagellates Alexandrium, Gymnodinium and Pyrodinium (Dittman et al., 2013;
Lefebvre et al., 2004). Saxitoxins exhibit their toxicity by reversibly binding to voltagegated sodium channels resulting in neurotoxic effects including nausea, numbness, ataxia,
and paralysis which can lead to death as a result of respiratory failure (Lefebvre et al.,
2004).
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Figure 1. 5: Structure of saxitoxin

1.2.3. Cytotoxic Alkaloids
Cylindrospermopsin (CYN) is characterized as a hepatotoxic, water-soluble cyclic
guanidinium alkaloid which also causes general cytotoxic and neurotoxic effects (Figure
1.6; Ohtani et al., 1992). Cylindrospermopsin was originally isolated from the
cyanobacterium belonging to the genera Cylindrospermopsis but subsequently found in
other freshwater cyanobacterial genera such as Anabaena, Aphanizomenon, Lyngbya,
Raphidiopsis, and Umezakia (Harada et al., 1994; Banker et al., 1997; Li et al., 2001;
Seifert et al., 2007). Predominantly, occurrence of CYN has been reported in the tropical
and subtropical regions in water reservoirs such as lakes, rivers, and ponds; however
reports have indicated their presence in more temperate environments (Neilan et al.,
2003; Fastner et al., 2007).
The toxicity of CYN was originally determined because of an outbreak of
symptoms of gastroenteritis among more than 100 children from an Aboriginal
community on Palm Island in Queensland, Australia. The cause of the illness was
subsequently linked to a contaminated water supply (Solomon Dam) containing a dense
algal bloom, which contained a strain of C. raciborskii. Even though CYN has been
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termed a hepatotoxin as a result of its main in vivo effect, it has been shown to target
other organs including the lungs, heart, kidneys, adrenal glands, and others (LópezAlonso et al., 2013). Considerable efforts have been made to identify the specific toxicity
of CYN however these effects are still unclear. The toxicity of CYN is thought to be
associated with the inhibition of protein synthesis and glutathione production (Runnegar
et al., 2002; Humpage et al., 2005).

Figure 1. 6: Structure of cylindrospermopsin

1.2.4. Dermatotoxic Alkaloids
Lyngbyatoxin-a (LTX) is an indole-containing alkaloid, produced by the marine
cyanobacterium Lyngbya majuscula which is typically found in coastal and estuarine
waters of tropical and subtropical environments (Fiure 1.7; Dittman et al., 2013)
Lyngbyatoxin is a highly potent skin irritant that is known to cause the condition,
Swimmer’s Itch, by specific activation of protein kinase C (PKC). Human exposure with
the cyanobacteria causes the development of erythema and blisters and has also been
found to be highly toxic to fish and other grazer species (Cardellina et al., 1979).
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Figure 1. 7: Structure of lyngbyatoxin

Aplysiatoxin (APX) (and debromoaplysiatoxin) are phenolic bislactones that along
with LTX are thought to be the cause of contact dermatitis associated with L. majuscula
(Figure 1.8; Moore et al., 1984). In addition to cyanobacteria, APXs have also been
detected in the red alga Gracularia coronopifolia (Ito & Nagai, 1998). Toxicity of APX also
occurs through ingestion and causes symptoms such as vomiting, diarrhea, and bleeding in
the small intestine with the suggested mode of action being an activator of protein kinase C
(Ito and Nagai, 2000).

Figure 1. 8: Structure of aplysiatoxin
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1.2.5. Other Cyanobacterial Toxins
β-methylamino-ʟ-alanine (BMAA) is a non-proteinogenic amino acid (Figure 1.9)
that was originally isolated from cycads and subsequently isolated from an endophytic
cyanobacterium (genus Nostoc) that resided in the specialized roots of the Guam cycad
plants (Banack et al., 2007). It has since been found in other taxonomic groups of
cyanobacteria, both free-living and bloom forming strains. The amino acid is thought to
be associated with neurodegenerative diseases such as dementia and amyotrophic lateral
sclerosis (ALS) however further research is essential to identifying its mode of action and
health risks from environmental exposure (Chiu et al., 2011; Okle et al., 2013).
The mechanism of action of BMAA is still being investigated however there are
studies that have indicated that it acts as a glutamate receptor agonist, such as NMDA,
AMPA, ionotropic and metabotropic glutamate receptors. It has also been suggest to
increasing oxidative stress by the inhibition of the cysteine/glutamate antiporter system
which prevents the uptake of cysteine thereby causing depletion in glutathione (Chiu et
al., 2011). Continued research is being done to get a better understanding of the mode of
action of this neurotoxin and how it relates to neurodegeneration.

Figure 1. 9: Structure of BMAA

13

Lipopolysaccharides (LPS) are characteristic structural components of the outer
membrane of Gram-negative bacteria, including cyanobacteria. The structure of LPS is
comprised of four segments covalently linked: lipid A moiety (acylated glycolipid), a
core oligosaccharide (made up of an inner and outer segment) and an O-specific chain
(carbohydrate polymer on the surface). Cyanobacterial LPSs are thought to be different,
both in structure and function, from Gram-negative bacteria, where one study showed
that cyanobacterial LPSs lacks significant endotoxin activity due to the structural
differences in the lipid A moiety (Stewart et al., 2006). There are limited studies on LPS
as cyanobacterial toxins; however some studies have shown that health effects associated
with these LPSs have a wide range and can include gastro-intestinal illness, skin rashes,
allergy, respiratory disease, headache, fever, and other health incidents (Stewart et al.,
2006).

1.3. Biosynthetic Pathways of Cyanobacterial Secondary Metabolites
The structures of majority of the cyanobacterial secondary metabolites are peptides,
peptide-like structures or polyketides. The common biosynthetic pathways associated
with the production of cyanobacterial secondary metabolites are the non-ribosomal
peptide synthetase (NRPS) for the peptidic structures, and polyketide synthase (PKS)
pathways for the polyketide structures. There is also a hybrid NRPS/PKS pathway that is
also involved in the production of the peptidic metabolites (Dittman et al., 2013).
Secondary metabolites that have cyclic or branched-cyclic structures, or small
peptides with unusual or modified amino acids typically indicated the involvement of a
non-ribosomal biosynthetic pathway. The NRPS biosynthetic pathway can be standalone
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or can occur in hybrid enzyme complexes, often with the PKS pathway as a result of the
structural and mechanistic similarities of the biosynthetic pathway. Non-ribosomal
peptide synthetases are made up of large modular, multi-enzyme complex, in which each
module has a role in different stages of the synthesis such as activation, thiolation,
modification, and condensation of an amino acid substrate. The organization and order of
the NRPS modules within the complex follows the co-linearity rule where it corresponds
with that of the amino acid sequence within the peptide product (Dittman et al., 2001).
The other biosynthetic pathway that is commonly observed in cyanobacteria is the
PKS pathway which, similar to NRPS, involves a family of modular enzymes which are
organized as functional units. Each PKS unit catalyzes specific reactions in the
elongation of the polyketide chain with each unit comprising of at least a ketosynthase
(KS), acyl transferase (AT) and acyl carrier protein (ACP) domain. The carbon backbone
of the polyketides is biosynthesized by decarboxylative condensation of acyl coenzyme A
(Acyl-CoA) subunits, typically using acetate as building blocks. Further modification to
the backbone can then be made by various subsequent enzyme “modules” (e.g.,
ketoreductases (KR), dehydrogenases (DH)) into the final biosynthetic product (Snyder et
al., 2003).

1.3.1. Non-Ribosomal Peptide Synthetase/Polyketide Synthase (NRPS/PKS)
Most of the biosynthetic pathways involved in cyanobacterial toxin production
seem to involve a hybrid NRPS/PKS pathway, including the well-studied hepatotoxic
cyclic peptide MCYST and its related pentapeptide NOD, the hepatotoxic alkaloid CYN,
and the neurotoxic alkaloid, ATX. The biosynthetic route for the cyclic peptides
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(MCYST and NOD) was thought to be similar and feeding experiments as well as their
unusual structure suggested that biosynthesis was of non-ribosomal origin (Moore et al.,
1991).
The MCYST biosynthetic gene cluster (mcyS) is 55kb and comprises of ten genes
(McyA-J) with two bidirectional operons (mcyA-C and mcyD-J). The larger operon
(mcyD-J) encodes for two NRPS/PKS hybrid (McyE and G) modules and a PKS (McyD)
modules involved in the formation of the Adda moiety. This operon also encodes for
enzymes involved in the modification (McyF, J, and I) and transport (McyH) of MCYST.
Operon mcyA-C encodes for three NRPS modules (McyA-C) which is involved in the
extension to the heptapeptide as well as subsequent cyclization (Tillett et al., 2000 and
Pearson et al., 2010). The course of reactions for MCYST biosynthesis is the same across
different genera of cyanobacteria with some variation in domain specificities (Dittman et
al., 2013). The proposed biosynthetic pathway for NOD is similar to that of MCYST and
the assignments of the enzymes were made on the basis of the homology with the
MCYST enzymes combined with bioinformatics analysis. The NOD gene cluster (ndaS)
is 48kb and consisting of nine open reading frames (ORFs; ndaA-I) and are also
assembled with a bidirectional operon. The mixed NRPS/PKS (NdaC, D, and F) modules
are involved in the formation of the Adda side chain and the two NRPS (NdaA and B)
modules are involved in adding the other amino acids for completion of the cyclic
pentapeptide (Pearson et al., 2010; Dittman et al., 2013).
The putative biosynthesis genes for CYN were identified in A. ovalisporum, with
the gene products involved being an amidinotransferase (AoaA), a NRPS/PKS hybrid
(AoaB), and a PKS (AoaC) along with other unidentified enzymes (Shalev-Alon et al.,
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2002). The complete CYN biosynthesis gene cluster from C. raciborskii (cyr) was
subsequently revealed by genome walking to be 43kb and encodes for 15 ORFs and
includes all the necessary functions for the biosynthesis, regulation, and transport of the
toxin. The corresponding homologs of AoaA, B, and C are CyrA, B, and C respectively.
The first step in the biosynthesis involves the formation of the guanidinoacetate catalyzed
by CyrA followed by activation via CyrB is thought to be involved in the second step.
Subsequent steps involve the elongation and modifications by PKS modules (CyrC, D, E,
and F). The ring formations are thought to occur spontaneously, leaving the other gene
products for the final biosynthesis, tailoring and transport of the toxin (Mihali et al.,
2008).
Biosynthesis of ATX was thought to involve the PKS pathway as a result of
feeding experiments that indicated that the carbon skeleton was derived from acetate and
glutatmate (Hemcheidt et al., 1995). The ATX biosysnthesis gene cluster (ana) encodes
for seven proteins (AnaA-G) with the proposed biosynthetic route being in two stages.
The first stage in the biosynthesis begins with proline as the starter unit activated by
AnaC (a NRPS-type adenylation protein) then subsequently loaded on AnaD (an ACP).
The second stage then involves elongation, cyclization, and modification on the PKS
(AnaE, F, and G) modules. This proposed biosynthetic route was suggested based on
feeding experiments and bioinformatics analysis (Mejean et al., 2010; Mann et al., 2011).

1.3.2. Non-ribosomal Peptide Synthetase
The LTX biosynthesis gene cluster (ltx) consists of four genes (ltxA-D) making it
the smallest cluster identified in the known cyanobacterial toxin biosynthesis. Feeding
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studies of teleocidin (a closely related toxin in Streptomyces sp.) helped to identify LTX
biosynthesis, revealing the incorporation of L-valine and L-tryptophan into the
indolactam ring. The proposed structure involves the condensation of N-methyl-L-Val
and L-Trp by LtxA (NRPS) followed by its release by reductive cleavage. LtxB (a
cytochrome P450 monooxygenase) is involved with the formation of the indolactam ring
with LtxC (phetnytransferase) involved in the generating the quaternary carbon by adding
a geranyl group to the indolactam core (Huynh et al., 2010).

1.3.3. Other Biosynthetic Pathways
The biosynthetic route for STX does not follow the typical NRPS or PKS pathway.
Radioisotope feeding experiments suggested that arginine, acetate, and methionine
methyl were involved in the biosynthesis with subsequent confirmation using a reverse
genetics approach (Kellmann & Neilan, 2007). The STX gene cluster (stx) was first
identified in C. raciborskii as a 35kb gene locus with homologous clusters being found in
other genera ranging in size from 25.7-36 kb. The toxin profile expressed by these
clusters depends on the presence and the organization of the stx genes. The initiation of
STX biosynthesis is thought to involve the methylation of acetate and a Claisen
condensation reaction with arginine by an unusual PKS-like enzyme, StxA. Subsequent
reactions include three heterocyclizations and tailoring reactions, which give rise to
different isoforms of the toxin (Kellmann et al., 2008).
The biosynthetic pathways for the neurotoxic, BMAA and the dermatotoxin, APX
have yet to be elucidated.
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1.4. Zebrafish Embryo Model
Zebrafish (Danio rerio) are small freshwater fish that have been an integral part of
laboratory studies for the past few decades especially as it relates to the effects of various
chemicals on developmental processes and identifying the cellular and molecular
mechanisms involved. There are many attributes of the zebrafish that makes its use
suitable as a developmental model such as their small size, ease of husbandry, high
fecundity, transparent chorion, and rapid embryonic development. Zebrafish mating and
breeding can occur almost all year round producing a large number of eggs (hundreds and
sometimes thousands) with one breeding. The embryos are very small (about 1mm in
diameter) and at 7 days post fertilization (dpf) can grow up to about 4 mm in length
which allows for the use of multiple embryos with each exposure and use in highthroughput exposures, using minimal amounts of toxicant. Additionally, embryos can
survive on its yolk for up to 7dpf, so exposure studies can be done without the
complication of added food. The embryos develop in a transparent chorion making the
examination and monitoring of the developmental features easily achieved using a
dissecting light-microscope. Zebrafish undergo rapid embryonic development (See
Figure 1.10) with most of the internal organs being fully developed by 96 hours post
fertilization (hpf), which therefore produces a quick response with exposure studies. Even
though zebrafish are not the only teleost fish that possess these characteristics, the added
advantage to using the zebrafish above these other teleost fish lies in the completely
elucidation of the genome which allows them to be used for additional studies, including
genetic studies.
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Figure 1. 10: Stages of development of the zebrafish embryo taken using an Olympus camera
attached to a dissecting microscope: A - Newly fertilized embryo, B - 1dpf, C - 2dpf, D – 3dpf, E
- newly hatched embryo.

The zebrafish has been implemented as a model for various studies as a result of
their applicable attributes to different areas of study. One of these has been the use of
zebrafish as a model of vertebrate development (Oberemm et al., 1997; Papendorf et al.,
1997; Veldman et al., 2008). It has also been an ideal genetic system for the study of
developmental and human disease (Dodd et al., 2000; Zhu & Zon, 2002), including
neurological diseases (Best et al., 2008) and developmental neurotoxicology (Linney et
al., 2004). More recently, the zebrafish has been used for drug screening and discovery,
especially in the area of cardiovascular drug discovery (Rocke et al., 2009). The zebrafish
model has also been used for toxicological studies of various natural occurring toxins,
specifically in the identification and characterization of developmental toxins from
marine dinoflagellates and cyanobacteria (Berry et al., 2007) as well as the toxic effects
of cylindrospermopsin (Berry et al., 2009). They have also been used to study selected
detoxifying enzymes in response to various toxins, such as microcystin (Wiegand et al.,
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1999), lipopolysaccharides in conjunction with microcystin (Best et al., 2002), and
natural organic matter on microcystin toxicity (Cazenave et al., 2006).

1.4.1. As a model for vertebrate development and toxicological studies
Much research has been carried out using the zebrafish as a model for toxicological
studies of various natural occurring toxins. The zebrafish embryo model has been
previously used in the study of several of the known toxins from cyanobacteria (e.g.
Lefebvre et al., 2004; Wang et al., 2005; Berry et al., 2009). Wang et al. (2005) carried
out a study to analyze the effects of microcystin on zebrafish embryos. During the study,
it was observed that microcystin was not taken up by the embryo, and as such
microinjections of embryos were required, after which the effects of the toxin became
apparent. A similar study was done with cylindrospermopsin, showing that
microinjection was also required in order to observe the effects of the toxin (Berry et al.,
2009). Even though these toxins are water-soluble in nature, there seems to be some
prevention in the uptake of these toxins in the embryo. Within the same study, Berry et
al. (2009) tested the lipophilic extracts of eight different isolates of cyanobacteria,
including cylindrospermopsin-producing C. raciborskii and A. ovalisporum and noncylindrospermopsin producing C. raciborskii, and showed that there were developmental
effects on the zebrafish embryos. These studies showed that the compounds responsible
for the bioactivity were unrelated to the known toxins from those strains of
cyanobacteria, which is evident because of the apparent lipophilic nature of the bioactive
extract, and as bioactivity was seen in non-cylindrospermopsin producing strains of
cyanobacteria.
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1.4.2. Bioassay-guided fractionations using zebrafish embryos
The zebrafish embryo has been previously used in the bioassay-guided
fractionations of bioactive metabolites from various sources as a model for vertebrate
development as it relates to inhibition of development and as a model for natural product
discovery (Crawford et al., 2011; Liu et al., 2011; Han et al., 2012) as it relates to
inhibition of angiogenesis. This model has also been implemented in the screening of
small molecules for the discovery of cardiovascular drugs (Novodvorsky et al., 2013).

1.5. Research Objectives
Cyanobacteria are known to produce a diverse repertoire of biologically active
secondary metabolites. When associated with so-called “harmful algal blooms”,
particularly in freshwater systems, a number of these metabolites have been associated as “toxins”, or commonly “cyanotoxins” - with human and animal health concerns
(Valério et al., 2010; Carmichael, 2008; Ferrão-Filho and Kozlowsky-Suzuki, 2011). It is
notable, although perhaps not surprising, that all of these recognized toxins are generally
polar and water-soluble metabolites. Previous studies have identified the presence of
uncharacterized toxic lipophilic metabolites in toxic and non-toxic strains of cyanoHABs
which may give rise to the toxigenicity of the species (e.g. Falch et al., 1995; Nogueira et
al., 2006; Berry et al., 2009).
Recently, Berry et al. (2009) showed that lipophilic extracts (not containing CYN
or STX) from C. raciborskii and A. ovalisporum inhibit the development of zebrafish
embryos. Additionally, a screening was done with the lipophilic extracts of other
cyanobacterial isolates, including a few cyanoHABs, which also showed the bioactivity
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of the previously identified isolates as well as bioactivity with other cyanobacterial
isolates (Table 1.1). Over thirty (30) isolates of cyanobacteria and green algae were
obtained and the lipophilic extracts were screened at a representative low and high
dosage for bioactivity using the zebrafish embryo bioassay. The extracts from ten isolates
of cyanobacteria and green algae showed mortality and inhibition of development at sublethal dosages up to 5dpf (Table 1.1). The lipophilic extracts from the cyanobacteria
isolates that showed bioactivity were Aphanothece 80-12a, Pseudanabaena 108-1,
Microcystis 81-11, Aphanizomenon APH, and two isolates of C. raciborskii 121-1 and
AQS, four of which belong to genera that are considered cyanoHABs. The lipophilic
extracts from the green algae that showed bioactivity were Chlamydomonas 80-1,
Kirchneriella 104-7, and two different isolates of Scenedesmus 79-1 and 80-15.

Table 1. 2: Cyanobacteria and green algae chloroform extracts that were used in the screening
against the zebrafish embryos, indicating the ones that showed bioactivity by inhibiting their
development.

Isolates

Chloroform Extracts / µL
10
100

Cyanobacteria
Aphanothece 103-7
Aphanizomenon APH
C. raciborskii 121-1
C. raciborskii AQS
Microcystis 81-11
Pseudanabaena 108-1
Green Algae
Chlamydomonas 80-1
Kirchneriella 104-7
Scenedesmus 79-1
Scenedesmus 80-15

X
X
X
X
X
X
X
X

Note: Isolates in bold are from genera that are considered cyanoHABs.
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X
X
X
X
X
X
X
X
X
X

1.5.1. Specific Aims
In continuity to these preliminary findings, the current study was developed to
focus on the identification of these lipophilic bioactive metabolites that contribute to the
toxicity of these cyanoHABs. The study therefore implemented the use of the zebrafish
embryo bioassay as a model for vertebrate development to guide the isolation of these
compounds for subsequent characterization of these ‘toxic’ lipophilic metabolites. As
such, the specific aims were as follows:
a) Isolate and characterize bioactive compounds within the lipophilic extract of known
toxigenic

strains

of

freshwater

cyanobacteria,

namely

Microcystis

spp.,

Cylindrospermopsis raciborskii, and Aphanizomenon ovalisporum. The collection
sites for the isolates are indicated in the table below.
Table 1. 3: Cyanobacterial isolates used in this study and their sources of origin.

Cyanobacterial Isolate
A. ovalisporum
C. raciborskii 121-1
C. raciborskii AQS
M. aeruginosa 81-11

Source of Origin
Lake Kinneret, Israel
Catemaco, Mexico
Townsville, Australia
Bay of Quinte, Lake Ontario

b) Develop an analytical method to effectively identify and quantify the bioactive
compounds and evaluate the occurrence, and possible bioaccumulation, of these
compounds in freshwater sources.
i. A modification to this objective was to evaluate the occurrence of the bioactive
compounds in different genera and species of cyanobacteria, since locating
freshwater sources known to have these identified and characterized bioactive
compounds would be difficult.
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ii. An addition to this objective involved doing feeding experiments with 13C-labeled
acetate to test the hypothesis that biosynthesis of the polymethoxy-1-alkenes
(PMAs) is via the polyketide biosynthetic pathway.
c) Toxicological characterization of the purified compounds was focused on the
developmental defects of the zebrafish including mortality, hatching rates, and
inhibition of development.
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CHAPTER 2*
POLYMETHOXY-1-ALKENES FROM APHANIZOMENON OVALISPORUM AND
CYLINDROSPERMOPSIS RACIBORSKII INHIBIT VERTEBRATE DEVELOPMENT
IN ZEBRAFISH (DANIO RERIO) EMBRYOS
(*This chapter has been modified from Jaja-Chimedza et al., 2012, Marine Drugs.)
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2.1. Introduction
Cyanobacteria (“blue-green algae”) are known to produce a diverse repertoire of
biologically active secondary metabolites (Valério et al., 2010). When associated with socalled “harmful algal blooms”, particularly in freshwater systems, a number of these
metabolites have been associated - as “toxins”, or commonly “cyanotoxins” - with human
and animal health concerns (Valério et al., 2010; Carmichael, 2008; Ferrão-Filho and
Kozlowsky-Suzuki, 2011). As health concerns have largely been associated with
exposure to drinking water contaminated with these toxins (except BMAA), it is notable,
although perhaps not surprising, that all of these recognized toxins are generally polar
and water-soluble metabolites. Previous evaluation of crude, non-polar (i.e., chloroform)
extracts from strains of both C. raciborskii and A. ovalisporum identified developmental
toxicity, clearly unrelated to the presence of CYN, and specifically associated with
apparent lipophilic metabolites from extracts of all of the isolates evaluated (Berry et al.,
2009).
C. raciborskii has been specifically associated with the production of the
hepatotoxic alkaloid, cylindrospermopsin (CYN), as well as the neurotoxic saxitoxin
(STX) and its analogues. Aphanizomenon, as a genus, and particularly the species, A.
flos-aquae, is a recognized producer of CYN, as well as the neurotoxic saxitoxin and
anatoxin-a. Although A. ovalisporum is not known to produce either saxitoxin or
anatoxin-a, studies of the Lake Kinneret isolate (Banker et al., 1997; Banker et al., 2000)
identified both CYN and its 7-epimer (i.e., 7-epi-CYN). Interestingly, and relevant to the
present study, during the isolation of the latter CYN congener, a series of isotactic
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polymethoxy-1-alkenes (4-6; Figure 2.1) were concurrently identified, purified and
chemically characterized.
Indeed, in the present study, bioassay-guided fractionation, as described below,
led to the isolation, and chemical characterization of these previously identified
polymethoxy-1-alkenes (PMAs), i.e., 4-6, as well as three additional members (1-3) of
the apparent homologous series (Figure 2.1), as lipophilic developmental toxins from the
Lake Kinneret strain of A. ovalisporum. Although three of the six PMAs reported here
have been isolated previously from this strain (Banker et al., 2000) - as well as at least
two other genera (i.e., Scytonema, Tolypothrix) of the cyanobacterial order Nostocales
(Mynderse and Moore, 1979; Mori et al., 1991a and 1991b) - in studies spanning more
than three decades, they have not previously been associated with toxicity. In addition to
their isolation, and chemical characterization, we report here on their developmental
toxicity in the zebrafish embryo model, and specifically, the apparent synergistic activity
of congeners in the series.

Figure 2. 1: Structure of polymethoxy alkenes (1-6) isolated in the current and previous studies.
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2.2. Results and Discussion
2.2.1. Purification of PMAs by Bioassay-Guided Fractionation
Biomass from unialgal cultures of A. ovalisporum was twice extracted in CHCl3,
and pooled extracts were confirmed to inhibit zebrafish embryo development as
previously documented (Berry et al., 2009). The pooled crude extracts were subsequently
fractionated (see Experimental Section) by silica gel column chromatography and
reverse-phase HPLC, affording a bioactive fraction containing a total of six components
(1-6; Figure 2.2). LC-MS of the active fraction identified nominal masses of the
presumptive molecular ions (M + H+) for compounds 1–6 of m/z 505 (1), 563 (2), 621
(3), 679 (4), 737 (5) and 795 (6), in addition to apparent, i.e., M + 23, sodium adducts (M
+ Na+) and M + 39, potassium adducts (M + K+) of each (Figure 2.3). An incremental
mass difference of 58 amu, corresponding to -CH2CH(OCH3)- units, between each of the
six compounds, as well as collision induced fragmentations, corresponding to sequential
losses of 32 amu (-OCH3 lost as CH3OH) for each compound, was consistent with a
homologous series of PMAs, as previously observed for the strain (Banker et al., 2000)
as well as other cyanobacteria (Mynderse and Moore, 1979; Mori et al., 1991a and
1991b). Each of the six peaks was collected for subsequent chemical and toxicological
characterization (as described below).
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Figure 2. 2: Chromatogram showing PMAs (1-6) isolated by HPLC from A. ovalisporum. See
experimental section for details.
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2.2.2. Structure Elucidation of the PMAs from A. ovalisporum
Compound 3 was the most abundant of the purified compounds and was isolated
as a white amorphous solid. A molecular formula of C34H68O9 was suggested by highresolution MS (HRMS; m/z 621.4920 [M + H]+), and subsequently confirmed by 1H and
13

C-NMR studies (see below). MS/MS of the presumptive molecular ion (m/z 621.5) in

the triple quadrupole instrument identified nine sequential losses of 32 amu consistent
with nine methoxy groups (as CH3OH) from the molecule (Figure 2.4). 1H NMR (Table
1), likewise, revealed eight signals at δ 3.1641 (s, 3H), 3.2105 (s, 3H), 3.218 (s, 3H),
3.2432 (s, 3H), 3.2514 (s, 3H), 3.2708 (s, 3H), 3.2745 (s, 3H) and 3.2798 (s, 6H),
consistent with nine methoxy groups, with two of the methoxy groups being equivalent
(Figure 2.5b).
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Figure 2. 4: LC-MS (low-resolution) of purified PMA 3 showing the sequential loss of m/z 32
corresponding to the loss of methoxy groups.

39

Figure 2. 5: 1H-NMR of PMA 3 from A. ovalisporum; a) the total 1H-NMR spectrum and b) the
signals observed for the methoxy protons showing 8 singlets corresponding to 9 methoxy groups
(27H) with two of the methoxy groups being equivalent.

Proton signals were observed at δH 5.09 (H-1E), 5.13 (H-1Z) and 5.93 (H-2),
integrating to 3H, suggesting the presence of a terminal alkene, and a signal at δH 2.30,
integrating to 2H, which suggests the presence of a methylene group attached to the
terminal alkene determined based on the COSY correlation (see below). A triplet was
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observed at δH 0.91, integrating to 3H which was assigned to the methyl group (C-25).
Two sets of overlapping multiplets at δ 3.37 (m, 2H) and 3.65 (m, 7H) (Table 2.1) were
assigned as oxymethine hydrogens geminal to the methoxy groups as well as overlapping
multiplets at δ 2.04 (m, 8H), 1.80 (m, 6H), 1.67 (m, 2H), 1.56 (m, 2H), 1.43 (m, 2H) and
1.30 (m, 4H), which integrated to a total of 24 protons. Based on distinct chemical shifts,
and the assumption that 3 was a PMA, 16 of these were tentatively assigned to the
protons vicinal to methoxy groups (δ 2.04, 1.80 and 1.67), and the remaining eight
protons (δ 1.56, 1.43 and 1.30) were assigned to methylenes at C-21 to C-24 positions
(Figure 2.6). Tentative proton assignments, and the proposed molecular formula, were
confirmed by

13

C-NMR and DEPT, as well as subsequent COSY, HMQC and HMBC

experiments, as described below.

Figure 2. 6: Proposed structure of PMA 3 with carbons numbered.
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Table 2. 1: 1H (C6D6, 400.13 MHz) and 13C (C6D6, 100.61 MHz) NMR Data for
4,6,8,10,12,14,16,18,20-nonamethoxy-1-pentacosene from A. ovalisporum (3).

C#
1

δC
117.01

2
3
4
5, 7 ,9…19
6, 8, 10…18
20
21
22
23
24
25
26-34

135.26
38.66
77.61
38.35-38.97
75.92-76.11
78.13
33.96
25.09
32.51
23.08
14.27
56.93-56.16

δH (mult, J in Hz; #H)
5.13 (dd,17,2; 1H)*
5.09 (dd,10,2; 1H)*
5.93 (ddt,17,10,7; 1H)
2.30 (m; 2H)
3.37 (m; 1H)
1.67-2.04 (m; 16H)
3.65 (m; 7H)
3.37 (m; 1H)
1.56 (m; 2H)
1.43 (m; 2H)
1.30 (m; 2H)
1.30 (m; 2H)
0.91 (t, 7.1; 3H)
3.16-3.28 (s; 27H)

COSY
H-2
H-2
H-1, H2-3
H-2, H-4
H-3, H2-5
See text
See text
H2-21, H2-19
H2-20, H2-22
H2-21, H2-23
H2-22, H2-24
H2-23, H2-25
H2-24

HMBC
H2-3
H2-3
H2-3
H2-1, H1-2
H3-26
See text
See text
H3-34
See text
See text
See text
See text
H2-24, H2-23
H-4,6…H-20

*Due to poor resolution, further splitting could not have been determined beyond the doublet of
doublet.

Figure 2. 7: 1H-NMR of PMA 3 showing the terminal alkene
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Figure 2. 8: 1H-NMR of PMA 3 showing the terminal methyl group.

The DEPT-135 experiment helped to support the assignments of the protons from
the 1H-NMR by indicating differentiating the presence of ‘CH’ and ‘CH3’ carbons
(positive signals) from ‘CH2’ carbons (negative signals) (Figure 2.9). The experiment
showed a positive carbon signal at δ 135.26 and a negative signal at δ 117.01 supporting
the assignment of the terminal alkene, as well as a negative signal at δ 38.66 supporting
the assignment of the allylic protons. A positive signal was observed at δ 14.27 which
also supports the presence of a methyl group. Overlapping positive signals were observed
between δ 56.93-56.16 and overlapping positive signals at δ 75.92-78.13 corresponding
to the methoxy carbons (-OCH3) and the oxymethine carbons (-CHOCH3) respectively.
Negative signals were also observed at δ 23.08, 25.09, 32.51, and 33.96 indicating
methylene carbons which were assigned a chain of four CH2 connected to the terminal
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methyl carbon (-CH2CH2CH2CH2CH3). The 1D 13C-NMR did not show additional carbon
signals, suggesting that no quaternary carbons were present in the structure (Appendix
A2.1.3D).

Figure 2. 9: DEPT-135 experiment differentiating the ‘CH’ and ‘CH3’ carbons (positive signals)
from the ‘CH2’ carbons (negative signals).

COSY experiments, in conjunction with HMQC and HMBC, revealed the
apparent linear structure of 3. Protons of the single methyl group (H3-25, δ 0.91) were
found to correlate by COSY to two pairs of hydrogens (δ 1.30) that were revealed, by
HMQC correlations, to be bonded to two methylene carbons (as confirmed by DEPT135). HMBC correlation of both methylene carbons to protons of the methyl group
further enabled assignment of C-25, -24 and -23. COSY correlation of C-23/24 protons to
a single pair of methylene protons (assigned as C-22), and subsequent correlation to a
single adjacent pair of methylene protons (assigned as C-21) - as well as COSY
correlation of C-21 hydrogens to a pair of oxymethine protons (δ 3.37) - enabled
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assignments of hydrogens on C-25 through C-20. Similarly, at the alkene terminal,
COSY correlation was observed between alkene hydrogens and a single pair of
methylene protons that was consequently assigned to C-3. Although methylene protons
on both C-21 and C-3 correlated to the same two overlapping oxymethine proton signals
(assigned C-20 and C-4, respectively), correlation of these protons to C-22 methylene and
C-1/2 terminal alkene protons, respectively, allowed these two pairs of methylene
hydrogens to be clearly distinguished.
The data from the heteronuclear 2D experiments (HMQC and HMBC) obtained
for compound 3, were used to confirm the assignments of the chemical shifts and the
connectivities within the structure. The HMBC data showed the correlation between the
signal at δ 0.91 (CH3 protons) and the signals at δ 23.08 and 32.51 confirming the
assignments of C-24 and C-23 respectively as previously established from the HMQC.
The methylene signals at δ 1.30-1.56 did not show any correlation, possibly due to the
low concentration of the sample. Correlations were also observed for the signal at δ 2.30
(allylic CH2) with the signals at δ 77.61, 117.01, and 135.26 confirming the methylene
connectivity to the terminal alkene as well as assigning the signal at δ 77.61 as C-4.
Overlapping signals at δ 3.16-3.28 (methoxy protons) were coupled to the signals at δ
75.92-76.11 (oxymethine carbons) and δ 38.35-38.97 (methylene carbons) which shows
the 2 and 3 bond coupling between the heteroatoms confirming the assignments of the
alternating methoxy groups. The other set of overlapping signals of the methylene
protons at δ 1.67-2.04 were coupled to the signals at δ 75.92-76.11 (oxymethine carbons)
and δ 38.35-38.97.
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Figure 2. 10: Total COSY spectrum of PMA 3 from A. ovalisporum.
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Figure 2. 12: HMQC of PMA 3 from A. ovalisporum with terminal alkene zoomed in.
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Finally, a stretch of nine alternating methoxy-bearing carbons and the methylene
carbons between (C-4 to C-20; Figure 2.6) were identified based on correlations in COSY
and HMBC. HMBC correlations between proposed methoxy carbons (nine in total) and
seven remaining oxymethine protons, along with mass fragmentation (i.e., loss of 32
amu) consistent with –OCH3 functional groups, further confirmed their identity as
methoxy-bearing carbons. Chemical shifts, in both 1H- and 13C-NMR spectra, assigned to
protons and carbons of the remaining methylenes and oxymethines, overlapped
considerably, and did not consequently allow resolution of these signals for direct
correlations. However, COSY and HMBC correlation of the total integrated signals for
the methylene and oxymethine protons (i.e., 16 and 9, respectively) and corresponding
carbons (i.e., 8 and 9, respectively) confirmed that methoxy-bearing carbons alternated
with methylenes.
Accordingly, 3 was determined to be 4,6,8,10,12,14,16,18,20-nonamethoxy-1pentacosene. As such, this compound would represent a structural isomer of
4,6,8,10,12,14,16,18,22-nonamethoxy-1-pentacosene previously isolated from the same
strain by Banker et al. (2000). Although a new PMA variant for this particular strain, 3
was, in fact, previously isolated by Mynderse and Moore (1979) from Tolypothrix
conglutinata var. colorata - specifically as the similarly most abundant (~80%) of three
congeners isolated from this strain - as well as by Mori et al. (1991a) from Scytonema
burmanicum. In this case, as in other prior studies (Banker et al., 2000; Mori et al., 1991a
and 1991b), the methoxy groups of the PMA were determined, based on NMR studies, to
be isotactic (i.e., on the same side of the alkene chain). Based on the nearly identical 1Hand 13C-NMR observed here, 3 was proposed to be, likewise, isotactic.
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Although quantities of each of the less abundant PMAs purified, including the
more major (i.e., 2 and 4) and minor (i.e., 1, 5 and 6; see Figure 2.2) congeners, did not
generally allow for 13C-NMR and related NMR analysis (i.e., HMQC, HMBC), structures
were assigned based on comparison to the 1H-NMR and associated assignments based on
COSY of 3 (as described above), as well as MS/MS (i.e., losses of 32 amu corresponding
each methoxy group). Furthermore, comparison of this data (i.e., 1H-NMR, COSY, MS)
to that previously published and available for characterization of PMAs, and specifically,
studies by Mynderse and Moore (1979) and Mori et al. (1991a and 1991b), were used to
support these structural assignments. A clear correlation (e.g., nearly identical 1H-NMR
chemical shifts, identical molecular ions and subsequent fragmentation patterns) between
spectroscopic data obtained for 2 and 4-6 in the present study, as well as those previously
reported (Mynderse and Moore, 1979; Banker et al., 2000; Mori et al., 1991a), support
our structural determinations for these less abundant variants. On the other hand,
although 1 has not been previously identified from any other source, consistency in the
NMR and MS data for this congener, compared to the other purified in the present study,
strongly support the proposed structure of this variant. Similar to 3, the stereochemistry and specifically the assignment as isotactic methoxy groups - was, likewise, concluded
based on the similarities observed in the NMR data for these congeners and those
previously characterized (Banker et al., 2000; Mori et al., 1991a and 1991b).
Accordingly, 1 and 2 were identified as isotactic 4,6,8,10,12,14,16-heptamethoxy-1uncosene and 4,6,8,10,12,14,16,18-octamethoxy-1-tricosene, respectively. The former
variant (1) has not been previously isolated (to the authors’ knowledge) from
cyanobacteria, however, the latter (2) was previously isolated from T. conglutinata
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(Mynderse and Moore, 1979). On the other hand, 4-6 were identified as
4,6,8,10,12,14,16,18,20,22-decamethoxy-1-heptacosene, 4,6,8,10,12,14,16,18,20,22,24undecamethoxy-1-nonacosene and 4,6,8,10,12,14,16,18,20,22,24,26-dodecamethoxy-1hentriacontene, respectively, and each has been previously isolated from the Lake
Kinneret isolate of A. ovalisporum (Banker et al., 2000) and other cyanobacteria (Mori et
al., 1991a and 1991b). Additional members of the apparent homologous series, including
penta- and hexa-methoxylated variants, although not seen here, have been previously
isolated from species of Scytonema (Mori et al., 1991a and 1991b).

2.2.3. Structure Elucidation of the PMAs from C. raciborskii
Purification of the PMAs from C. raciborskii was done according to the procedure
as describe for A. ovalisporum. Five of the six PMAs isolated from A. ovalisporum were
identified in C. raciborskii, based on the high-resolution LC-MS data (Figure 2.14),
however only four of the PMAs (2-5) were purified by HPLC (Figure 2.13). The resulting
chemical characterization was similar to the PMAs isolated from A. ovalisporum and the
other cyanobacterial stains previously shown to produce these compounds (Mynderse and
Moore, 1979; Mori et al., 1991a and 1991b; Rao and Faulkner, 2002; Jaja-Chimedza et
al., 2012). All four compounds obtained from the purification were white amorphous
solids.

High-resolution mass spectral data for all four compounds were obtained;

[M+H]+ 563.4488 (2), 621.4900 (3), 679.5312 (4), and 737.5733 (5), which allowed for
the determination of the molecular formulas C31H62O8 (2), C34H68O9 (3), C37H74O10 (4),
C40H80O11 (5), which were further confirmed by NMR analyses.
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Figure 2. 13: HPLC Chromatogram of the four PMAs purified from C. raciborskii with UV
detection at 200 nm.
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Figure 2. 14: High resolution LC-MS analysis of a crude fraction of C. raciborskii showing the
presence of five PMAs (1-5); a) chromatogram of the PMAs and b) mass spectral data of the
PMAs.
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Fragmentation of the molecular ion of each of the compounds showed a sequential
loss of m/z 32 corresponding to the number of methoxy groups associated with the
compound, indicating the presence of a polymethoxylated structure. Mass spectral data
also showed that the masses of the four polymethoxy-1-alkenes differed from the next by
a mass of 58, corresponding to the -CH2CH(OCH3)- unit (See Figure 2.14). This is
consistent with that observed from the polymethoxy-1-alkenes isolated from other
cyanobacterial strains (Mynderse and Moore, 1979; Mori et al., 1991a and 1991b; Banker
et al., 2000; Jaja-Chimedza et al., 2012) and sponge (Rao and Faulkner, 2002).

Figure 2. 15: 1H-NMR of PMA 3 from C. raciborskii; a) the total 1H-NMR spectrum and b) the
signals observed for the methoxy protons showing 8 singlets corresponding to 9 methoxy groups
(27H) with two of the methoxy groups being equivalent.
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The NMR data showed signals and splitting patterns were similar to those observed
for the PMAs isolated from the other strains of cyanobacteria. 1H and COSY NMR
spectroscopic data were obtained for all the compounds with the exception of PMA 2 due
to the low amount of the compound purified (57μg). Chemical shifts and connectivities
were similar for all three compounds and so analysis of compound 3 will represent what
was observed for the other two PMAs. The 1H-NMR showed 8 signals at δ 3.1637 (s,
3H), 3.2101 (s, 3H), 3.2174 (s, 3H), 3.2427 (s, 3H), 3.2508 (s, 3H), 3.2705 (s, 3H),
3.2742 (s, 3H), and 3.2792 (s, 6H) corresponding to 9 methoxy groups. The NMR signals
for the terminal alkenes were observed at δ 5.07 (1H-1E), 5.10 (1H-1Z), and 5.90 (ddt,
1H-2), which was coupled to the signal at δ 2.30 (2H-3) for the methylene hydrogens (m;
2H). The methylene signal was then coupled to a signal δ 3.37 corresponding to one of
the oxymethine hydrogens (2H), designated H-4. The signals observed at δ 0.91 (t; 3H),
1.30 (m; 4H), 1.42 (m; 2H), and 1.56 (m; 2H), corresponds to the terminal methyl group
and subsequent methylene groups respectively, making up the alkyl chain (CH2CH2CH2CH2CH3) at the end of the molecule, based on the couplings observed from
the COSY experiment. The methylene signal at δ 1.56 (m; 2H) was then coupled to an
oxymethine signal at δ 3.37, designated H-20. The oxymethine multiplets at δ 3.37 and
3.64 (8H) were coupled to the overlapping multiplets from δ 1.67 – 2.03 (16H).
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Table 2. 2: 1H (C6D6, 400.13MHz) and 13C (C6D6, 100.61MHz) NMR data for
4,6,8,10,12,14,16,18,20-nonamethoxy-1-pentacosene (3) from C. raciborskii.

C#

δC

1

117.35

2
3
4
5, 7 ,9…19
6, 8, 10…18
20
21
22
23
24
25
26-34

135.56
38.35
77.89
38.54-38.97
75.92-76.11
78.42
34.26
25.40
32.82
23.40
14.60
56.24-56.47

δH (mult, J in Hz;
#H)
5.10 (dd, 17,2; 1H)
5.07 (dd, 10,2; 1H)
5.90 (ddt,17,10,7; 1H)
2.30 (m; 2H)
3.37 (m; 1H)
1.67-2.03 (m; 16H)
3.64 (m; 7H)
3.37 (m; 1H)
1.56 (m; 2H)
1.42 (m; 2H)
1.30 (m; 2H)
1.30 (m; 2H)
0.91 (t, 7.1; 3H)
3.16-3.28 (s; 27H)

COSY

HMBC

H-2
H-2
H-1, H2-3
H-2, H-4
H-3, H2-5
See text
See text
H2-21, H2-19
H2-20, H2-22
H2-21, H2-23
H2-22, H2-24
H2-23, H2-25
H2-24

H2-3
H2-3
H2-3
H2-1, H1-2
H3-26
See text
See text
H3-34
See text
See text
See text
See text
H2-24, H2-23
H-4,6…H-20

The heteronuclear 2D experiments, HMQC and HMBC data were obtained for
compound 3 which were used to confirm the assignments of the chemical shifts and
determine the long range connectivities between the protons and carbons respectively
(See Table 1). The HMBC data showed the connectivities of the methoxy proton signals
at δ 3.16-3.28 coupled to signals at δ 75.92-78.42, the oxymethine signals at δ 3.37-3.64
coupled to the signals at δ 56.24-56.47 and the methylene protons at δ 1.67-2.03 coupled
to signals at δ 75.92-78.42. Specific correlations were observed for the methylene protons
at δ 2.30 coupled to the terminal alkene signals (δ 5.07, 5.10, and 5.90) and the signal at δ
77.89 (designated C-4). The terminal methyl signal at δ 0.91 was coupled to the signals at
δ 23.40 and 32.82 confirming the designations of C-24 and C-23 respectively. The NMR
and mass spectral data obtained correlates with those observed for other PMAs identified
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in other strains of cyanobacteria (Mynderse and Moore, 1979; Mori et al., 1991; JajaChimedza et al., 2012).
The PMAs isolated in this study, with the exception of PMA 1, were previously
isolated from other strains of cyanobacteria, however not enough material was purified to
obtain relative or absolute stereochemistry. However, the absolute stereochemistry of the
PMAs isolated from the cyanobacteria, Scytonema, were determined by carrying out a
direct comparison with the optically active synthetic compounds (Mori et al., 1991a and
1991b). Based on the synthesis, it was determined that the PMA from S. burmanicum and
S. ocellatum (Mori et al., 1991a), specifically the nonamethoxy-1-pentacosene, was
slightly different in structure from the PMA from S. ocellatum (Mori et al., 1991b) with
the location of one of the methoxy groups (C-34) being on C-22 instead of C-20 (Figure
2.16). Other PMAs with a similar structure were also isolated from S. ocellatum with one
of the methoxy groups being located on a different carbon atom. These two structures
however differed slightly in their chemical shifts as well as their optical rotation (done in
CHCl3 at 25oC, c = +4.73 for 4,6,8,10,12,14,16,18,20-nonamethoxy-1-pentacosene and c
= +11.20 for 4,6,8,10,12,14,16,18,22-nonamethoxy-1-pentacosene). The NMR data
obtained for PMA 3 in this study supports the assignment of 4,6,8,10,12,14,16,18,20nonamethoxy-1-pentacosene, however not enough sample was obtained to do optical
rotation for further confirmation based on the synthesis of these compounds in the
previous studies.
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Figure 2. 16: Two different forms of nonamethoxy-1-pentacosene isolated from different species
of Scytonema previously determined by synthesis (Mori et al., 1991a and 1991b)

A model of the 3D structure of PMA 3 (based on the proposed structure as
determine above) was generated using Chem3D Pro 12.0 Ink which shows the structure
resembling a cork screw with the methoxy groups sticking out of the carbon backbone
(Figure 2.17).

Figure 2. 17: A model of the 3D structure of PMA 3 from Chem3D Pro 12.0 Ink.

57

2.3. Experimental Section
2.3.1. Culturing of the Cyanobacteria
The isolates of A. ovalisporum, (designated APH 127-1) and C. raciborskii
(designated CAQS) were grown, as previously described (Berry et al., 2007; Berry et al.,
2009; Gantar et al., 2008), in 3-L flasks in BG11 medium under cool-white fluorescent
light (intensity 30 μEm-2·s-1) with aeration. The cells/biomass were harvested after three
to four weeks by centrifugation and freeze-dried.

2.3.2. Extraction and Isolation of Polymethoxy-1-alkenes
Isolation and purification of the polymethoxy-1-alkenes was carried out by a
bioassay-guided fractionation using the zebrafish embryo model. Freeze-dried biomass of
A. ovalisporum and C. raciborskii was extracted in chloroform in a 10:1 ratio overnight.
The filtered extract was initially fractionated by flash chromatography on a normal phase
silica-gel glass column (Silica Gel 60Å, Commercial 40–63 μm) with a stepwise gradient
of ethyl acetate in hexane; a bioactive fraction (as identified with the zebrafish embryo
toxicity assay; see Chapter 4) eluted with 100% ethyl acetate. This bioactive (i.e., 100%
ethyl acetate) fraction was further separated by reverse-phase HPLC (Phenomenex Luna
5 μm C18 100 Å LC Column 250 × 4.6 mm; solvent gradient of 50:50 acetonitrile/water
to 100% acetonitrile for 37 min at a flow rate of 1ml/min) with UV detection (i.e., 200
nm absorbance). The crude mixture of all six polymethoxy-1-alkenes eluted with
retention times between 21 and 24 min. This mixture of polymethoxy-1-alkenes was
confirmed to be toxic in the zebrafish embryo model (see Chapter 4), and individual
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PMAs were purified by HPLC-UV (isocratic 65:35 acetonitrile/water) with the
compounds eluting in order of increasing size (see Figure 2.2 and 2.3).

2.3.3. Characterization of Polymethoxy-1-alkenes from A. ovalisporum
Purified compounds were characterized by NMR and mass spectrometry. 1H- and
13

C/DEPT-135 NMR, as well as two-dimensional homonuclear (i.e., COSY) and

heteronuclear (i.e., HMQC and HMBC) analyses, were done on a Bruker AVANCE 400
MHz instrument. Mass spectrometry was performed on a Thermo TSQ Quantum Access
ESI/triple quadrupole instrument coupled to a Thermo Accela UHPLC; high-resolution
mass spectrometry data was done on a Thermo LTQ ESI-Orbitrap.

4,6,8,10,12,14,16-Heptamethoxy-1-uncosene (1): HRESIMS m/z 505.4067 (C28H56O7,
[M + H]+, mmu of -3.18); 1H NMR (400 MHz, benzene-d6) δ 0.91 (t, 3H, J = 7.1 Hz),
1.30 (m, 4H), 1.43 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.81 (m, 4H), 2.02 (m, 6H), 2.30
(m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s, 3H), 3.27 (s, 3H),
3.27 (s, 3H), 3.37 (m, 2H), 3.64 (m, 5H), 5.07 (dd, 1H, J = 10,2 Hz), 5.09 (dd, 1H, J = 17,
2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz).

4,6,8,10,12,14,16,18-Octamethoxy-1-tricosene (2): HRESIMS m/z 563.4222 (C31H62O8,
[M + H]+, mmu of -3.56); 1H NMR (400 MHz, benzene-d6) δ 0.91 (t, 3H, J = 7.1 Hz),
1.30 (m, 4H), 1.42 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.81 (m, 5H), 2.03 (m, 7H), 2.30
(m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s, 3H), 3.27 (s, 3H),
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3.27 (s, 3H), 3.28 (s, 3H), 3.37 (m, 2H), 3.64 (m, 6H), 5.07 (dd, 1H, J = 10, 2 Hz), 5.09
(dd, 1H, J = 17, 2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz).

4,6,8,10,12,14,16,18,20-Nonamethoxy-1-pentacosene (3): HRESIMS m/z 621.4900
(C34H68O9, [M + H]+, mmu of -3.95); 1H NMR (400 MHz, benzene-d6) δ 0.91 (t, 3H, J
= 7.1 Hz), 1.30 (m, 4H), 1.43 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.80 (m, 6H), 2.04
(m, 8H), 2.30 (m, 2H), 3.1641 (s, 3H), 3.2105 (s, 3H), 3.218 (s, 3H), 3.2432 (s, 3H),
3.2514 (s, 3H), 3.2708 (s, 3H), 3.2745 (s, 3H), and 3.2798 (s, 6H), 3.37 (m, 2H), 3.65 (m,
7H), 5.09 (dd, 1H, J = 10, 2 Hz), 5.13 (dd, 1H, J = 17, 2 Hz), 5.93 (ddt, 1H, J = 17, 10, 7
Hz);

13

C NMR (100 MHz, benzene-d6) δ 14.3, 23.1, 25.1, 32.5, 33.9, 38.0, 38.2, 38.3,

38.6, 38.6 (3C), 38.7 (4C), 55.9, 56.0, 56.0 (3C), 56.0 (2C), 56.1, 56.1, 75.6, 75.7 (2C),
75.7, 75.8, 77.6, 78.1, 117.0, 135.3.

4,6,8,10,12,14,16,18,20,22-Decamethoxy-1-heptacosene (4): HRESIMS m/z 679.5312
(C37H74O10, [M + H]+, mmu of -4.08); 1H NMR (400 MHz, benzene-d6) δ 0.91 (t, 3H, J
= 7.1 Hz), 1.30 (m, 4H), 1.44 (m, 2H), 1.58 (m, 2H), 1.68 (m, 2H), 1.81 (m, 7H), 2.03
(m, 9H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s, 3H),
3.27 (s, 3H), 3.27 (s, 3H), 3.28 (s, 9H), 3.37 (m, 2H), 3.64 (m, 8H), 5.07 (dd, 1H, J = 10,
2 Hz), 5.10 (dd, 1H, J = 17, 2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz).

4,6,8,10,12,14,16,18,20,22,24-Undecamethoxy-1-nonacosene

(5):

HRESIMS

m/z

737.5728 (C40H80O11, [M + H]+, mmu of -4.51); 1H NMR (400 MHz, benzene-d6) δ
0.91 (t, 3H, J = 7.1 Hz), 1.30 (m, 4H), 1.44 (m, 2H), 1.57 (m, 2H), 1.68 (m, 2H), 1.81 (m,
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8H), 2.03 (m, 10H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H),
3.25 (s, 3H), 3.27 (s, 6H), 3.27 (s, 3H), 3.28 (s, 9H), 3.37 (m, 2H), 3.64 (m, 9H), 5.07
(dd, 1H, J = 10, 2 Hz), 5.10 (dd, 1H, J = 17, 2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz).

4,6,8,10,12,14,16,18,20,22,24,26-Dodecamethoxy-1-hentriacontene (6): HRESIMS m/z
795.6150 (C43H86O12, [M + H]+, mmu of -4.22); 1H NMR (400 MHz, benzene-d6) δ
0.91 (t, 3H, J = 7.1 Hz), 1.30 (m, 4H), 1.44 (m, 2H), 1.57 (m, 2H), 1.68 (m, 2H), 1.81 (m,
9H), 2.03 (m, 11H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H),
3.25 (s, 3H), 3.27 (s, 6H), 3.27 (s, 3H), 3.28 (s, 12H), 3.37 (m, 2H), 3.64 (m, 10H), 5.07
(dd, 1H, J = 10, 2 Hz), 5.10 (dd, 1H, J = 17, 2 Hz), 5.90 (ddt, 1H, J = 17, 10, 7 Hz).

2.3.4. Characterization of Polymethoxy-1-alkenes from C. raciborskii
Purified compounds were characterized by NMR and mass spectrometry. 1H- and
13

C/DEPT-135 NMR, as well as two-dimensional homonuclear (i.e., COSY) and

heteronuclear (i.e., HMQC and HMBC) analyses, were done on a Bruker AVANCE 400
MHz instrument. Mass spectrometry was performed on a Thermo TSQ Quantum Access
ESI/triple quadrupole instrument coupled to a Thermo Accela UHPLC; high-resolution
mass spectrometry data was done on a Thermo LTQ ESI-Orbitrap.

4,6,8,10,12,14,16,18-Octamethoxy-1-tricosene (2): HRESIMS m/z 563.4489 (C31H62O8,
[M + H]+, mmu of -2.90); 1H NMR (400 MHz, benzene-d6) 3.1643 (s, 3H), 3.2114 (s,
3H), 3.2185 (s, 3H), 3.2437 (s, 3H), 3.2525 (s, 3H), 3.2715 (s, 3H), 3.2750 (s, 3H),
3.2810 (s, 3H).
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4,6,8,10,12,14,16,18,20-Nonamethoxy-1-pentacosene (3): HRESIMS m/z 621.4900
(C34H68O9, [M+H]+, mmu of -3.64); 1H NMR (400MHz, benzene-d6) δ 0.91 (t, 3H, J =
7.1 Hz), 1.30 (m, 4H), 1.42 (m, 2H), 1.56 (m, 2H), 1.67 (m, 2H), 1.81 (m, 6H), 2.03 (m,
8H), 2.30 (m, 2H), 3.1637 (s, 3H), 3.2101 (s, 3H), 3.2174 (s, 3H), 3.2427 (s, 3H), 3.2508
(s, 3H), 3.2705 (s, 3H), 3.2742 (s, 3H), and 3.2792 (s, 6H), 3.37 (m, 2H), 3.64 (m, 7H),
5.07 (dd, 1H, J = 10,2 Hz), 5.10 (dd, 1H, J = 17,2 Hz), 5.90 (ddt, 1H, J = 17,10,7 Hz);
13

C NMR (100MHz, benzene-d6) δ 14.6, 23.4, 25.4, 32.8, 34.3, 38.3, 38.5, 38.6, 38.9,

38.9 (3C), 39.0 (4C), 52.2, 56.3, 56.3 (3C), 56.4 (2C), 56.5, 75.9, 76.0 (2C), 76.1, 76.1,
77.9, 78.4, 117.3, 135.6.

4,6,8,10,12,14,16,18,20,22-Decamethoxy-1-heptacosene (4): HRESIMS m/z 679.5312
(C37H74O10, [M+H]+, mmu of -4.27); 1H NMR (400MHz, benzene-d6) δ 0.91 (t, 3H, J =
7.1 Hz), 1.30 (m, 4H), 1.42 (m, 2H), 1.55 (m, 2H), 1.67 (m, 2H), 1.81 (m, 7H), 2.02 (m,
9H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s, 3H), 3.27
(s, 3H), 3.27 (s, 3H), 3.28 (s, 9H), 3.37 (m, 2H), 3.65 (m, 8H), 5.07 (dd, 1H, J = 10,2 Hz),
5.10 (dd, 1H, J = 17,2 Hz), 5.90 (ddt, 1H, J = 17,10,7 Hz).

4,6,8,10,12,14,16,18,20,22,24-Undecamethoxy-1-nonacosene

(5):

HRESIMS

m/z

737.5733 (C40H80O11, [M+H]+, mmu of -4.08); 1H NMR (400MHz, benzene-d6) δ 0.91
(t, 3H, J = 7.1 Hz), 1.30 (m, 4H), 1.44 (m, 2H), 1.58 (m, 2H), 1.68 (m, 2H), 1.81 (m, 8H),
2.04 (m, 10H), 2.30 (m, 2H), 3.16 (s, 3H), 3.21 (s, 3H), 3.22 (s, 3H), 3.24 (s, 3H), 3.25 (s,
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3H), 3.27 (s, 6H), 3.28 (s, 12H), 3.37 (m, 2H), 3.65 (m, 9H), 5.07 (dd, 1H, J = 10,2 Hz),
5.10 (dd, 1H, J = 17,2 Hz), 5.90 (ddt, 1H, J = 17,10,7 Hz).

2.4. Conclusions
In the present study, the zebrafish embryo model was used to identify, isolate (via
bioassay-guided fractionation) and characterize a homologous series (Figures 2.1 and 2.2)
of isotactic PMAs, including one novel variant, as toxic components of the lipophilic
fraction of the Lake Kinneret isolate of A. ovalisporum and the Australia isolate of C.
raciborskii. To our knowledge, this is the first report of the PMAs as toxic or otherwise
bioactive metabolites. It is, accordingly, suggested that these metabolites may not only
explain previously observed developmental toxicity (Berry et al., 2009) of lipophilic
fractions from A. ovalisporum and C. raciborskii, but that these previously unrecognized
(as toxic) components may contribute to the overall toxicity of these CYN-producing
bloom species, and to the cyanobacteria perhaps more generally. Indeed, the prior
isolation of these compounds (albeit as non-toxic metabolites) from other cyanobacterial
species (Banker et al., 2000; Mynderse and Moore, 1979; Mori et al., 1991a and 1991b;
Rao and Faulkner, 2002) may suggest that these toxic metabolites are relatively
widespread, particularly within the cyanobacteria. As such, these findings suggest a need
to further investigate these possibly widespread toxic metabolites of the cyanobacteria.
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CHAPTER 3
THE APPARENT BIOSYNTHETIC PATHWAY FOR POLYMETHOXY-1-ALKENES
AND THEIR TAXONOMIC DISTRIBUTION IN DIFFERENT GENERA OF
FRESHWATER CYANOBACTERIA
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3.1. Introduction
It has been suggested that these PMAs are derived from the polyketide biosynthetic
pathway on the basis of their linear polymethoxylated structure, specifically their pattern
of 1,3-oxygenation, and their isolation with other toxins biosynthesized by this pathway
(i.e., cylindrospermopsin; Banker et al., 2000). It was also suggested that these
compounds are produced by the bacteria (A. ovalisporum) only when it was producing
CYN because PMAs could not be identified when the strain stopped producing the
cyanotoxin (Banker et al., 2000). This could indicate that PMAs are synthesized by
similar mechanisms to those of CYN as a result of the loss of production of these two
metabolites at the same time. According, this hypothesis was further tested to identify if
the biosynthesis of the PMAs involved the PKS biosynthetic pathway. Additionally, these
PMAs have been isolated from over three decades ago on the basis of their structure and
have subsequently been found in various other strains terrestrial, marine, and freshwater
cyanobacteria belonging to the order Nostocales (Mynderse and Moore, 1979; Mori et
al.,1991a and 1991b; Banker et al., 2000). It was therefore thought that these compounds
may be widespread and so a culture collection of different genera of cyanobacteria was
obtained to determine the prominence of these compounds.

3.1.1. Polyketide synthases biosynthetic pathway
The linear polymethoxylated structure of the PMAs suggests a possible
biosynthetic origin based on the polyketide synthase (PKS) pathway found conspicuously
throughout the secondary metabolism of fungi, bacteria and microalgae (Staunton and
Weissman, 2001). Indeed, this biosynthetic route - and specifically the sequential
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condensation of acetate - for the PMAs has been previously suggested by other authors.
Banker et al. (2000), for example, proposed such a biosynthetic origin as a result of both
consideration of structure, and the observation that PMAs were not found among A.
ovalisporum cultures that lost their ability to produce the PKS-derived CYN. Similarly,
both Mynderse and Moore (1979) and Mori et al. (1991a and 1991b) identified PMAs
from strains of Tolypothrix and Scytonema, respectively, known to produce the
polyketide, tolytoxin. Given the abundance of PKS-derived secondary metabolites among
cyanobacteria (examples Figure 3.1) and other microalgae, this biosynthetic origin may
further support a widespread distribution of the PMAs.

Cylindrospermopsin

Anatoxin-a

Microcystin

Figure 3. 1: Structure of compounds from freshwater cyanobacteria with biosynthesis involving
the PKS biosynthetic pathway.

Polyketides are a diverse group of secondary metabolites that are commonly found
in microorganisms (bacteria, fungi and microalgae) and are produced by a family of
modular enzymes called polyketide synthases (PKSs). The carbon backbone of the
polyketides is biosynthesized by way of Claisen Condensation of acyl coenzyme A
(CoA), using acetate as the starter units, and further modified into bioactive metabolites
(Snyder et al., 2003).
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Microorganisms that produce these readily uptake labeled substrates for the
biosynthesis of metabolites (Staunton and Weissman, 2001) and as such feeding
experiments with 13C-labeled acetate is commonly carried out to confirm biosynthesis via
the PKS pathway. In the current study, we report the identification and purification of a
series of PMAs (2-5) from a cultured strain of C. raciborskii (designated CAQS),
originally isolated from an aquaculture pond in Australia (Saker and Eaglesham, 1999)
and the suggested biosynthesis via the polyketide biosynthetic pathway.

3.1.2. Previously identified genera of PMA-producing cyanobacteria
Polymethoxy-1-alkenes (2-4) were first isolated from a terrestrial tolytoxinproducing cyanobacterium, Tolypothrix because of its unusual structure (Mynderse &
Moore, 1979). More than a decade later, these PMAs were isolated from another
tolytoxin-producing cyanobacterium, Scytonema burmanicum, with two additional
variants (n = 5 and n = 6) being found in S. mirabile (Mori et al., 1991a). Additionally
variations to these PMAs were identified in S. ocellatum, a cultured terrestrial tolytoxinproducing cyanobacterium (Mori et al., 1991b). Another decade later, similar PMAs (36) were identified in a cultured cylindrospermopsin-producing strain of A. ovalisporum,
isolated from Lake Kinneret, Israel. These PMAs were isolated according to their
structure because there were no signs of bioactivity by the conventional cell-based
assays. Recently, the zebrafish embryo was used in a bioassay-guided fraction for the
isolation of six PMAs from A. ovalisporum, with a novel variant (1, n =7), showing that
these compounds are indeed bioactive, thus contributing to the toxicity of these toxinproducing cyanobacterial strains.
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3.2. Results & Discussion
3.2.1. Biosynthetic Origin of PMAs
In order to investigate the possible biosynthetic origins of the 2-5, and specifically
the possible involvement of PKS pathways, cultures of C. raciborskii AQS were fed 113

C-labeled acetate (as a recognized “building blocks” of PKS-derived polyketides).

Subsequently, 2-5 were purified (as for unlabeled cultures; see Experimental Section
2.3.2) from

13

C-acetate-fed C. raciborskii cultures. Purified 2-5 were then analyzed for

the incorporation of 13C by LC-MS and NMR spectroscopy (1D: Inverse-gated decoupled
13

C).

Mass spectrometric analysis of the 13C-labeled PMAs: From partial purification of
the PMAs from CAQS fed with

13

C1-labeled acetate, we identified all six PMAs (1-6)

that were previously identified in A. ovalisporum, including minor uncharacterized
PMAs, with only 2-5 purified in sufficient quantities. All the PMAs identified showed
incorporation of

13

C as determined by the sequence of additional peaks with a m/z 1

observed in the MS data, suggesting that these compounds are synthesized via the PKS
pathway (Figure 3.2). PMA 3 was obtained in the highest quantity and was therefore used
for further LC-MS and NMR analysis. Analysis by LC-MS of purified 3 (Figure 3.3)
showed clear incorporation of

13

C-heavy atom, and specifically a sequential ladder of

masses starting from m/z 643 [M+Na]+ to m/z 658, indicating that a possible fourteen 13Catoms may have been incorporated (according to the number of additional m/z of +1
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observed). All the other PMAs showed a sequential ladder of m/z of +1, again indicating
the incorporation of the 13C atoms into the molecules (Figure 3.2).

3
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Figure 3. 2: LC-MS analysis of the isolated PMAs from CAQS showing the incorporation of the
13
C1-labeled acetate as shown from the additional m/z of +1.

Figure 3. 3: LC-MS analysis of purified 3 from C-AQS after the feeding experiments with the
labeled 13C1-acetate.
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The incorporation of

13

C-label via exogenous acetate generally confirms that 2-5

were biosynthesized by the cultured organism. It also indicates that this incorporation
from acetate, as biosynthetic building blocks, or alternatively by metabolic/catabolic
products derived from acetate. The incorporation is also generally consistent with the
PKS biosynthesis, however, to confirm that the pattern is by means of sequential
condensation of the acetate building blocks (according to the PKS mechanisms), NMR
studies were required.

NMR Analysis of the

13

C-Labeled PMAs: The specific areas of

13

C incorporation

were determined by NMR spectroscopy where an increase in the signals (relative to the
unlabeled signals) of the corresponding chemical shifts indicated an incorporation of the
carbon isotope. Isotopic enrichment was calculated using the method by Liu et al. (2012)
by determining the integration of the carbon signals for both the natural abundance and
enriched samples, and then calculating the percent of enrichment of the enriched sample
compared to the natural abundance sample. Signals showing enrichment greater than
200% indicates regions of incorporation. The purified samples of PMA 3 (both enriched
and natural abundance) were analyzed by NMR using the inverse-gated decoupled

13

C

experiment in order to reduce the enhancement effects from the attached protons. Carbon
signals were integrated for both samples, normalizing to a signal that is not expected to
be enriched and calculated for percent enrichment.
Assignments of the chemical shifts and the corresponding percent enrichment for
each signal is shown below in Table 3.1. Integration of the signals were normalized to C-
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25 and the overlapping signals were divided by the corresponding number of carbons for
the final % enrichment. Incorporation of the 13C-isotope was expected in the oxymethine
carbons (C-6, 8, 10,…,20) according to the patterns observed with the PKS pathway.
Enrichment was observed in the carbons assigned 1, 2, 22, 23, 24, and 25 which was not
in agreement with what was expected. As a result of the overlap of the signals for the
oxymethine carbons (C-6,8,…,18), methylene carbons (C-3,5,…,19), and the methoxy
carbons (C26-34), determination of individual enrichments was not possible.

Table 3. 1: Assignments of the carbons from 13C-NMR and the percent enrichment of each signal.
Integration of the signals was normalized to C-25.

Carbon assignments
2
1
4
20
3,5,7,..,19
26-34
6,8,10,…,18
21
23
22
24
25

δC (ppm)
117.35
135.56
77.89
78.42
38.35-38.97
56.24-56.47
75.92-76.11
34.26
32.82
25.40
23.40
14.60

Percent enrichment (%)
385.6
407.6
149.8
125.2
45.7
22.4
40.7
186.6
234.6
276.7
218.7
228.4

From the analysis of the NMR spectrum (Figure 3.4), splitting of the NMR signals
was observed in all the individual carbon signals (C1, C2, C3, C4, C20, C21, C22, C23,
C24, and C25) and partially in the overlapping signals of the oxymethine carbons (C6,
C8,…, C18) observed at δ 75.9-76.1 as well as the overlapping methylene carbons (C5,
C7,…,C19) observed at δ 38.9-39.0. As expected, there was no coupling observed for the
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methoxy carbons due to the presence of the adjacent heteroatom. The couplings observed
with the carbon signals indicate that there is incorporation of the 13C-isotope throughout
the alkyl chain of the molecule and not just in alternating signals as hypothesized
according to the PKS pathway. This ubiquitous incorporation of the
that the

13

C atom suggests

13

C1-labeled acetate was possibly metabolized and utilized by a different

biosynthetic pathway which uses the 13C atoms to synthesize the PMAs. Further analysis
is required to identify how these labeled carbon atoms are being incorporated into the
molecule.

Figure 3. 4: Inverse-gated decoupled 13C-NMR spectrum of purified 3.

The biosynthesis of PMAs by the PKS pathway was previously suggested by
Banker et al. (2000) where it was observed that PMAs were not observed in strains of
Aphanizomenon that no longer produced CYN (which is derived from the PKS
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biosynthetic pathway). Likewise, PMAs were also previously isolated from strains of
cyanobacteria that produce CYN (e.g., A. ovalisporum) or other PKS-derived toxins (e.g.,
tolytoxin; Mynderse and Moore, 1979 and Mori et al., 1991a and 1991b). In the current
study, PMAs were also identified from a CYN-producing strain of C. raciborskii (AQS),
however, they were not observed in our non-CYN-producing strain of the same species
(C. raciborskii 121-1; See Table 3.2). Further analysis of different strains of CYNproducing cyanobacteria will need to be analyzed to assess the co-occurrence of these
two compounds.

3.2.2. Taxonomic distribution of the PMAs
In order to determine the distribution of PMAs, algal isolates (ninety-seven
cyanobacteria and green algae) were analyzed for the presence of PMAs by LC-MS using
a data-dependent scan, using the [M+Na]+ as the target ion for each of the PMAs (Table
3.2). All three fractions (40% ethyl acetate in hexane, 100% ethyl acetate and 100%
methanol) were screened for the presence of the PMAs with the PMAs being found in the
40% ethyl acetate in hexane fraction, including fractions from APH and CAQS which
were used as controls to confirm that the methods for fractionation and MS analysis were
successful in identifying the PMAs. PMAs were identified in the 40% ethyl acetate
fraction.
From the data-dependent screening of the isolates, PMAs were observed in eight
isolates which included both cyanobacteria and green algae. Cyanobacterial isolates
identified to produce PMAs are Anabaena 66-2 (PMA 3), Microcystis 81-11 (PMA 3),
Nostoc 23-2 (PMAs 2-5), and Pseudanabaena 108-1 (PMAs 2-3), all of which belong to
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the order Nostocales with the exception of Microcystis which belongs to the order
Chroococcales. Green algae isolates in which PMAs were identified are Pediastrum 1046 (PMA 2), Scenedesmus 3-4 (PMAs 2-5), Scenedesmus 79-1 and 80-15 (PMAs 2-3).
Previously, PMAs were isolated from cyanobacterial strains belonging to the order
Nostocales (Mynderse and Moore, 1979; Mori et al., 1991a and 1991b; Banker et al.,
2000), however from this current screening, the PMAs seemed to be more widespread
being found in Microcystis (Order Chroococcales) and green algae, a different organism
than cyanobacteria.
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Table 3. 2: Screening of cyanobacterial and green algal extracts for the presence of PMAs analyzed by LC-MS in data-dependent scan mode.
PMAs were determined based on retention times and m/z of the [M+Na]+ ions.

Cyanobacterial Isolates

Polymethoxy-1-alkenes
1
2
3
4
5 6

Aphanizomenon
Cylindrospermopsis AQS

X
X

Arthronema 63a-5
Amatoidea/Calothrix 70-1
Anabaena 48-2
Anabaena 66-2
Anabaena S12
*Ankistrodesmus 45-2
Aphanothece 103-7
Aphanothece 104-9
Arthronema 37-8-1
Arthronema 63-1
Arthronema 95-2a
Calothrix 13-3
Calothrix 30-3
Calothrix 3-26
Calothrix 3-27
Calothrix 33-2
Calothrix 67-1
*Coelastrum 104-10

X
X

X
X

X
X

X
X

Cyanobacterial Isolates

X
X

Microcystis 95-11
Microcystis 95-12
Microcystis 95-13
Microcystis 95-4
Microcystis 99-1
Nostoc 15-7b
Nostoc 23-2
Nostoc 23-2a-1
Nostoc 64-15
Nostoc EV-1
Nostoc S2
Oscillatoria 101-1A8
Oscillatoria 21-9-3
*Pediastrum 104-6
Phormidium 49-1
Phormidium 62-2
Phormidium 64-13
Phormidium 69-9
Plectonema 33-7
Pseudanabaena 108-1
Pseudanabaena 81-4

X
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Polymethoxy-1-alkenes
1
2
3
4
5
6

X

X

X

X

X

X

X

Cyanobacterial Isolates

Polymethoxy-1-alkenes
1
2
3
4
5 6

Cyanobacterial Isolates

Cyanosarcina 33-3
Cylindrospermopsis 121-1
Dictiospherium 107-2
Fischerella 114-12
Fischerella 114-4
Fischerella 52-1
Fischerella 52-1
Gleocapsa 30-1-5
Gleocapsa 37-8
*Kirchneriella 104-2
Leptolyngbya 102c-1
Leptolyngbya 30-1-2
Leptolyngbya 69-2
Leptolyngbya 69-5
Leptolyngbya 71-2
Limnothrix 16-1
Limnothrix 21-2-2
Limnothrix 39-1
Limnothrix 48-1
Limnothrix 60-1
Lyngbya 105-2
Lyngbya 15-2
Lyngbya 29-3
Microcystis 22-6

Pseudanabaena 95-13a
Pseudoanabaena 69-7
Pseudoanabaena 73-2
Pseudocapsa 64-17
*Scenedesmus 3-4
*Scenedesmus 79-1
*Scenedesmus 80-15
Scytonema 26-1
Scytonema 26-1
Spirulina 21-0
Synechococcus 103-5
Synechococcus 21-10a
Synechococcus 21-11
Synechococcus 84-2a
Synechococcus 22-1
Synechococcus 47-1
Synechococcus 47-1
Synechococcus 71-3
Synechococcus 74-1
Synechocystis 104-3
Synechocystis 108-7
Synechocystis 63a-2
Synechocystis 79-3
Synechocystis 84-1
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Polymethoxy-1-alkenes
1
2
3
4
5
6

X
X
X

X
X
X

X

X

Cyanobacterial Isolates
Microcystis 36-1
Microcystis 75-1
Microcystis 81-11
Microcystis 84-2

Polymethoxy-1-alkenes
1
2
3
4
5 6

Cyanobacterial Isolates

Polymethoxy-1-alkenes
1
2
3
4
5
6

Tolypothrix 30-1-4
Tolypothrix 30-1-40
Tolypothrix 38-6
Tolypothrix 64-11

X

Note: Isolates with an asterisk (*) are green algae and the isolates in bold are those from which PMAs have been purified.
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3.3. Methods
3.3.1. 1-13C-labeled acetate feeding experiments
The polymethoxy-1-alkenes have slight resemblance to polyketides synthesized by
the polyketide-synthase mechanism. As such, this hypothesis was evaluated by doing a
feeding experiment with 1-13C-labeled acetate and evaluated for incorporation of

13

C in

the molecules. Cyanobacterial cultures (APH and CAQS) were grown in 3L flasks in
BG11 medium under cool-white fluorescent light (intensity 30µEm-2sec-1) with constant
aeration (Gantar et al., 2008). For feeding experiments, an actively growing culture of
CAQS was sub-cultured (see Section 2.3.1. Culturing of Cyanobacteria), and on days 2,
9, 16 and 23 supplemented with 500 mg of 1-13C-labeled acetate; cultured material was
harvested on day 25.

3.3.2. Purification of 1-13C-labeled PMAs and Chemical Characterization
Purification of the PMAs was carried out as before using the silica-gel column,
with the 100% ethyl acetate fraction containing the labeled PMAs. Two HPLC
purifications were performed to purify the PMAs; first with an increasing gradient of
acetonitrile in water followed by an isocratic elution of 65% acetonitrile with each PMA
being individually collected for chemical characterization. Mass spectral data was
obtained by LC-MS using a HESI source. To determine the percentage enrichment of 13C
in the PMAs, NMR experiments (specifically inverse-gated decoupled 13C) were carried
out and compared to those of the unlabeled PMAs.
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3.3.3. Preparation of cyanobacterial extracts for PMA screening
Ninety-seven algal isolates were obtained from a culture collection (obtained from
Dr. Miroslav Gantar, FIU) and prepared based on the isolation of the PMAs. Isolates
were extracted twice in chloroform, using the freeze-thaw method to break open the cells.
The samples were filtered and the extracts (supernatant) were dried down and resuspended in 1mL of chloroform. Extracts were fractionated using solid-phase extraction
(SPE) cartridge (Supelclean LC-Si SPE Tubes, bed weight 100mg, volume 1mL) and
three fractions were collected; 40% ethyl acetate in hexane, 100% ethyl acetate, and
100% methanol, with LC-MS analysis being done on all three fractions.

3.3.4. Mass spectrometric analysis of the occurrence of PMAs
All 3 fractions of the cyanobacterial isolates from the SPE were analyzed for the
presence of PMAs by LC-MS on a reversed-phase column (Phenomenex Kinetex 2.6 μm
C18 100 Å LC Column 100 × 4.6 mm). The fractions were analyzed using an acetonitrile
gradient starting with 50% acetonitrile in water for 5mins with an increasing gradient up
100% acetonitrile over 15mins and kept at 100% acetonitrile for 5mins for a total run
time of 25mins. A data-dependent MS analysis was done using electrospray ionization
(ESI), and the retention times and masses were evaluated for the presence of PMAs using
APH and CAQS as controls.

3.4. Conclusion
Analysis of the results from the feeding experiments testing the hypothesis that the
biosynthesis of the PMAs occurs via the PKS biosynthetic pathway were inconclusive,
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however there is some suggestion of a possibly different mechanism for the biosynthesis.
The MS analysis indicates that there is incorporation of the

13

C-labeled acetate,

suggesting a PKS biosynthetic route, however NMR analysis showed that incorporation
was seen throughout the entire molecule which is not consistent with the pattern of a PKS
biosynthetic route. It can be however be concluded that these compounds were
synthesized by the cultured organism. Further analysis is required to identify how the
labeled acetate is being incorporated into the compounds.
PMAs were previously thought to be produced by cyanobacteria in the order of
Nostocales. Results have shown that not only are they produced by many different genera
of cyanobacteria (terrestrial, marine, and freshwater), they are also produced by green
algae. This indicates that these molecules are widely produced in different environments,
as well as from different organisms. These compounds may therefore contribute to the
toxicity of cyanoHABs and other symbiotic organisms in various environments.
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CHAPTER 4*
ASSESSMENT OF THE TOXICOLOGICAL EFFECTS OF POLYMETHOXY-1ALKENES FROM APHANIZOMENON OVALISPORUM USING THE ZEBRAFISH
EMBRYO BIOASSAY
*A portion of the work described in this chapter has been published in the journal,
Marine Drugs (Jaja-Chimedza et al., 2012).
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4.1. Introduction
In several previous studies (Berry et al., 2004; Berry et al., 2007; Berry et al.,
2009; Walton et al., in preparation), we have utilized the zebrafish (Danio rerio) embryo,
as a model of vertebrate development, and specifically a toxicological (i.e. bioassay)
system, to investigate “developmental toxicity” (i.e. inhibition or impairment of
developmental pathways) of cyanobacterial secondary metabolites. The zebrafish embryo
has become an increasingly important vertebrate model owing to a number of practical
advantages including: a high fecundity capable of producing hundreds of eggs with a
single breeding; rapid embryonic development with most internal organs being fully
differentiated by 96 hours post fertilization (hpf); as well as a nearly transparent outer
chorion allowing for development to be easily monitored using a light microscope (Berry
et al., 2007). As such, this model system is finding utility in fields ranging from genetics
to toxicology/pharmacology to biotechnology (Teraoka et al., 2003; Hill et al., 2005). In
prior studies (Berry et al., 2004; Berry et al., 2007; Berry et al., 2009), the zebrafish
embryo assay has been specifically applied to identification (i.e screening), purification
(i.e. bioassay-guided fractionation) and characterization of developmental toxins from
cyanobacteria.
As part of this on-going research, Berry et al. (2009) previously evaluated the
hepatotoxin, cylindrospermopsin (CYN), as well as extracts from unialgal cultures of
several CYN producing and non-producing strains of the widespread toxigenic
cyanobacterial

species,

Cylindrospermopsis

raciborskii

and

Aphanizomenon

ovalisporum. Although CYN was found to be toxic, apparent impermeability of the
embryonic chorion and/or cellular membranes, with respect to the water-soluble toxin,
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necessitated microinjection of the pure compound for toxicity to be observed. In fact, a
similar apparent impermeability – and requirement for microinjection – was, likewise,
observed for the equally water-soluble microcystins (Wang et al., 2005). Moreover,
toxicity of microinjected CYN was generally only associated with a dose-dependent
increase in mortality of embryos, but no clear or reproducible developmental dysfunction
(Berry et al., 2009). In contrast, however, concurrent evaluation of crude, non-polar (i.e.
chloroform) extracts from strains of both C. raciborskii and A. ovalisporum identified
developmental toxicity, clearly unrelated to the presence of CYN, and specifically
associated with apparent lipophilic metabolites from extracts of all of the isolates
evaluated (Berry et al., 2009).
Toward understanding the possible contribution of these apparent lipophilic
metabolites to the toxigenicity of these cyanobacterial species, the present study used the
zebrafish embryo bioassay to guide purification for subsequent chemical and
toxicological characterization of the previously identified (Berry et al., 2009)
developmental toxin(s) from one of these isolates. Indeed, in the present study, bioassayguided fractionation, as previously described, led to the isolation, and chemical
characterization of these previously identified polymethoxy-1-alkenes (PMAs), i.e. 4-6,
as well as three additional members (1-3) of the apparent homologous series (Figure 2.1),
as lipophilic developmental toxins from the Lake Kinneret strain of A. ovalisporum.
Although three of the six PMAs reported here have been isolated previously from this
strain (Banker et al., 2000) - as well as at least two other genera (i.e. Scytonema,
Tolypothrix) of the cyanobacterial order Nostocales (Mynderse and Moore, 1979; Mori et
al., 1991a and 1991b) – in studies spanning more than three decades, they have not
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previously been associated with toxicity. We report here on their developmental toxicity
in the zebrafish embryo model, and specifically the apparent synergistic activity of
congeners in the series.

4.2. Results & Discussion
Crude extracts containing PMAs and purified PMAs (1-5) from both strains of
PMA-producing cyanobacteria were tested using the zebrafish embryos to have a better
understanding of its toxicological effects. Additional bioactivity was evaluated using
other bioasssays include mosquito larvicidal bioassay, cytotoxicity assay and antibacterial
assay.

4.2.1. Zebrafish Embryo Bioassay
Although previously isolated from A. ovalisporum (Banker et al., 2000), and
several other cyanobacterial species (Mynderse and Moore, 1979; Mori et al., 1991a and
1991b), PMAs have not been previously associated with toxicity or other bioactivity.
Indeed, Mynderse and Moore (1979) first isolated the isotactic PMAs, including 2, 3 and
4, as components of “non-toxic mixture,” while looking for the cytotoxic polyketide,
tolytoxin A. As such, the present study is the first report of the biological activity of the
PMAs. It should, however, be noted that a parallel series of polymethoxydienes isolated
from the marine sponge, Myriastra clavosa, were found to be moderately cytotoxic to a
human colon cancer cell-line, and suggested in fact, based on chemical similarity, to be
derived (via diet and metabolic transformation) from cyanobacteria (Rao and Faulkner,
2002).
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Individual PMAs: In the current study, five of the six PMAs (1-5) were obtained in
sufficient (i.e., accurately weighable) quantities, and subsequently evaluated for
developmental toxicity in the zebrafish embryo model. Zebrafish embryos, exposed (five
embryos per concentration) to a representative concentration range (10, 25, 50 and 100
μg mL-1) of 1-5, were observed up to five days post-fertilization (dpf) for mortality and
apparent developmental dysfunction. It should be noted that solubility, and consequently
the absolute dissolved concentration, of PMAs in aqueous assay medium remains
uncertain; however, the assumption of relatively low water-solubility of these lipophilic
compounds would suggest that prepared exposure concentrations may, in fact,
overestimate actual dissolved exposure concentrations.
Notably, toxicity of PMAs in the zebrafish embryo assay seemed to correlate with
chain length and/or associated degree of methoxylation of the variants. With regards to
embryo mortality (Table 4.1), no effect was observed at the lowest exposure
concentrations (10 and 25 μg mL-1) for any of the variants tested. In a typical experiment,
however, 100% mortality at 5 dpf was observed for embryos exposed to both 50 and 100
μg mL-1 of the three smallest congeners (1-3), whereas relatively little (i.e., 20%-40%) or
no mortality for the same doses were observed for embryos exposed to the two
increasingly larger congeners (i.e., 4 and 5, respectively) tested. For comparison,
mortality in untreated controls was very low (i.e., approximately 1.7%, n = 60 embryos).
Similarly, there was an apparently parallel, congener-dependent effect on hatching rates
(Table 4.1). Again, little or no effect on hatching (i.e., 80%-100% hatching rate at 4 dpf;
n = 5 eggs) was observed for lowest exposure concentrations (10 and 25 μg mL-1) of any
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of the PMAs tested relative to the untreated controls (98% hatching, n = 60 eggs).
However, the hatching of embryos was inhibited by PMAs in a dose- and congenerdependent manner at the two highest exposure concentrations (50 and 100 μg mL-1).
Specifically, hatching (4 dpf) was completely inhibited in embryos exposed to 100 μg
mL-1 of congeners 1-3, but only partially inhibited for embryos exposed to 4, and not
appreciably affected in embryos exposed to the largest variant tested (5). Supporting a
dose and congener dependent effect, at 50 μg mL-1 hatching was completely inhibited by
only the two smallest congeners (1 and 2), and decreasingly affected by the larger 3-5.
These observations were further supported by a preliminary evaluation of 3-5, which
were initially purified in sufficient quantities to test. This preliminary exposure study
showed a similar pattern to that reported in Table 4.1 for these congeners, with 3 causing
100% mortality as well as gross development defects at the highest concentrations tested
(50 and 100 μg mL-1), while 4 caused only low mortality (20%) at the highest
concentration (100 μg mL-1) and none at lower concentrations, and 5 did not cause
mortality at any exposure level at 5 dpf. Although little or no mortality was observed for
embryos exposed to 4 at these highest concentrations, all surviving embryos were
characterized by developmental dysfunction and deformity (as discussed further below);
in contrast, no distinguishable effects on development were observed for embryos
exposed to any concentration of 5. Thus, while the limited availability of purified
material precluded conducting a full-scale quantitative toxicological characterization of
the PMAs, the consistency of the trends observed strongly supports a dose and congener
related toxicity effect on these embryos.
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Table 4. 1: Mortality and Hatching Rates for Zebrafish Embryos Exposed to PMAs (1-5) from A.
ovalisporum (Lake Kinneret, Israel). Mortality was recorded at five days post-fertilization (dpf)
for five embryos per concentration. Hatching rates were recorded at 4 dpf.

% Mortality (5 dpf) b
PMA
a
Conc.:
1
2
3
4
5

10
20%
0%
0%
0%
0%

25
0%
0%
0%
0%
0%

50
100%
100%
100%
40%
0%

Hatching Rate (4 dpf) b
100
100%
100%
100%
20%
0%

10
100%
100%
100%
100%
100%

25
100%
80%
80%
100%
100%

50
0%
0%
40%
60%
80%

100
0%
0%
0%
60%
80%

a

Concentration of PMAs tested at 10, 25, 50 and 100 μg mL-1; b In treated wells n = 5 and in
untreated controls, mortality was approximately 1.7%, while hatching rate was 98% (n = 60
embryos).

In addition to the effects on mortality and hatching rate, there was also an
apparent correlation between both exposure dose and structural variation of the PMAs
(i.e., degree of methoxylation, chain length) and observed morphological developmental
effects (Figure 4.1). At the highest concentration tested (100 μg mL-1), embryos exposed
to the smallest congener (1) exhibited several indications of severely impaired
development (Figure 4.1E), including near lack of pigmentation, impaired organogenesis
(e.g., reduced eye formation), deformity of the yolk sac and other gross abnormalities.
Although developmental effects were less profound for congeners 2 and 3 at the same
exposure concentration (100 μg mL-1), embryos exposed to both of these larger variants
were also characterized (Figure 4.1F,G, respectively) by similar defects as well as the
formation of edemas (along with reduced hatching rates; see above). Developmental
dysfunction was uniformly observed (i.e., 100% of embryos), although the severity of
this dysfunction varied, and in each case, was followed by embryo mortality within 5-6
dpf. In contrast, embryos exposed to the highest dosage of congener 4 showed relatively
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limited developmental effects (e.g., slightly curved body axes; Figure 4.1H) and those
exposed to 5 were indistinguishable (data not shown) from untreated controls (Figure
4.1I). Development was also inhibited and abnormal in all embryos exposed to a lower
concentration (50 μg mL-1) of 1-3, but there was no clear correlation of prevalence or
severity of defects with congener size. (Figure 4.1A-C). However, similar to the effects
observed at the higher concentrations, there were clearly minimal effects of congener 4
(Figure 4.1D) and no detectable effects associated with 5. One particularly notable effect
observed was an apparent pooling of blood between the anterior surface of the yolk and
the heart in embryos exposed to 1-3 (indicated by arrows in Figure 4.1); this was most
obvious in embryos exposed to the lower concentration (50 μg mL-1) of all three of these
congeners and the higher concentration (100 μg mL-1) of the largest of these variants (3).
This effect was not observed in the more severely deformed embryos exposed to the
highest concentration of 1 and 2, where it was likely obscured by the numerous severe
developmental defects present in these fish. As for the assessment of mortality and
hatching rate (see above; Table 4.1), data from a single experiment are presented, due to
limitations of the purified PMAs. However, additional studies with a subset of these
congeners, including both evaluation of initially purified amounts of 3-5 (as discussed
above), and the subsequent evaluation of 3 and 4 with respect to apparent interactive
effects (Figure 4.2; discussed below), likewise generally confirm the observed congenerdependent trend of delayed and/or dysfunctional development.
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Figure 4. 1: Developmental Toxicity of PMAs (1-4) Isolated from A. ovalisporum (Lake
Kinneret, Israel). Photomicrographs of embryos at 4 dpf. Shown are embryos exposed to 1-4 at 50
μg mL-1 (A-D, respectively) and 100 μg mL-1 (E-H, respectively). Untreated control embryo at 4
dpf (I) shown for comparison. Arrows indicate areas where blood is pooled adjacent to the heart.
Images in A-C and E-G, are not to scale with D, H and I.

Synergistic Effects: Based on the qualitatively more pronounced developmental
toxicity observed during bioassay-guided fractionation compared to that of individual
congeners, we evaluated pair-wise combinations of 3 and 4 - as two of the most abundant
variants (i.e., purified in the largest quantity) with the latter showing only relatively
limited toxicity - in order to assess possible synergistic and/or additive effects of the
PMAs. Interestingly, a clear interactive effect of the congeners, in terms of embryos
toxicity, was observed for embryos exposed to a combination of two variants when
compared to either 3 or 4, individually. Embryos exposed to 50 and 100 μg mL-1 of each
compound were characterized by the typically moderate developmental dysfunction
observed for these variants (Figure 4.1 and 4.2A-C). However, when exposed to
equivalent total concentrations comprised of equal amounts congeners 3 and 4 (i.e., 25 μg
mL-1 and 50 μg mL-1, respectively, of 3 and 4), there was a clearly more pronounced
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inhibition of development (Figure 4.2D,E). All embryos exposed to both combined
concentrations were characterized by a severe inhibition of organogenesis and overall
differentiation and development of the embryo that was not observed for embryos
exposed to any of the congeners individually at an equivalent concentration. This
observation is consistent with a synergistic effect of these variants and may explain
increased toxicity of PMA mixtures (when compared to individual variants). Synergistic
interactions of biologically active cyanobacterial metabolites have been previously
reported. Recently, for example, Leão et al. (2010) documented similar synergistic
effects with regards to algicidal activity of the cyclic peptide congeners, portoamides A
and B, isolated as apparent allelochemicals from a freshwater strain of Oscillatoria.
Likewise, a similarly synergistic effect of lobocyclamides A and B, isolated from a
marine cyanobacterial species, Lyngbya confervoides, was previously reported
(MacMillan et al., 2002), specifically in relation to antifungal activity of these
lipopeptides.
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Figure 4. 2: Apparent synergistic interactions in the developmental toxicity of 3 and 4. Shown are
embryos exposed to 50 μg mL-1 of 3 (A), and 100 μg mL-1 of 3 (B) and 4 (C), compared to an
equivalent combined total concentration (i.e., 25 and 50 μg mL-1 of each) of the two variants (D
and E, respectively). Embryos shown at 4 dpf.

The identification of toxicity associated with the PMAs, combined with the
previous isolation of related variants from other distantly related marine, freshwater and
terrestrial cyanobacterial genera (Mynderse and Moore, 1979; Mori et al., 1991a and
1991b), as well as the cyanobacterially derived polymethoxydienes found in marine
sponges (Rao and Faulkner, 2002), suggests that PMAs may represent a relatively
widespread toxic metabolite from the blue-green algae. Moreover, preliminary evaluation
by LC-MS, and subsequent purification and identification (by MS and 1H-NMR),
confirmed the presence of 1-6 in the extracellular medium of the A. ovalisporum cultures
(data not shown), and suggests that these lipophilic metabolites may, to some degree, be
released - either actively by excretion, or passively via senescence of algal cells - into the

95

surrounding aqueous environment. Accordingly, it is proposed that the presence of these
lipophilic metabolites may not only contribute to previously observed toxicity associated
with lipophilic fractions of toxigenic cyanobacteria (Berry et al., 2009), but to the
observed toxicity of the bloom-forming cyanobacteria more generally.

4.2.2. Mosquito Larvicidal Bioassay
Mosquito larvae (Aedes aegyptii) were used to test for larvicidal activity of the
PMAs, using both crude extracts and purified compounds. Chloroform extracts of APH
and CAQS, and SPE fractions (40% ethyl acetate, 100% ethyl acetate, and 100%
methanol) were tested at different doses and bioactivity was observed over a period of 8
days. For the chloroform extracts, bioactivity was observed in doses of 10 and 50µL, with
no bioactivity being observed at 100µL. At 10µL, 25% mortality was observed by day 3
and 50% mortality was observed by day 5 until the end of the bioassay. At 50µL, 25%
mortality was observed at day 5 and for the rest of the bioassay. The only SPE fraction
that showed bioactivity was 100% ethyl acetate at 100µL where 25% mortality was
observed from day 4 onwards. There was 3% mortality observed for the controls and the
mortality occurred at day 6.
For the purified PMAs, bioactivity was only observed with PMA 4 at 100µg/mL in
both bioassays using the new and the old eggs. For the new eggs, no mortality was
observed up to 8 days, however the larvae were slow moving and there was slightly slow
development. At 5 days, the larvae were still at the 2nd instar stage and remained there
until day 7 after which further development slowly continued with the larvae being
noticeably smaller than the controls. There were no mortalities in the controls (solvent
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and water) and development was normal. For the old eggs, 25% mortality was observed
from day 2 to day 8. At day 3, all larvae were at the 1st instar stage and by day 5 only one
larva was at the 2nd instar stage. By day 6, all larvae were at the 2nd instar stage with one
larva being very early. This slow development continued throughout the rest of the
bioassay with only one larva reaching 3rd instar by the end of the bioassay. There were no
mortalities observed in the controls and development proceeded as normal.
In both new and old eggs, PMA 4 only showed slight bioactivity at the highest
concentration tested. None of the other PMAs showed any bioactivity suggesting that the
mosquito larvae are not very susceptible to these compounds. Though there was slow
development observed in the larvae exposed to PMA 4, there were no apparent
developmental abnormalities. This observed slow development was slightly more
pronounced in the old eggs than the new eggs, which is to be expected since the new eggs
tend to be more robust than the old eggs.

Table 4. 2: PMA exposures to mosquito larvicides, showing results at day 8 of the bioassay.

% Mortality (Instar) b
New Eggs (2 weeks)
PMA
a
Conc.:
1
2
3
4
5

10
0 (3)
0 (3)
0 (3)
0 (3)
0 (3)

25
0 (3)
0 (3)
0 (3)
0 (3)
0 (3)

50
0 (3)
0 (3)
0 (3)
0 (3)
0 (3)

% Mortality (Instar) b
Old Eggs (2 mnths)
100
ND
ND
ND
0 (2)
ND

10
0 (3)
0 (3)
0 (3)
0 (3)
0 (3)

25
0 (3)
0 (3)
0 (3)
0 (3)
0 (3)

50
0 (3)
0 (3)
0 (3)
0 (3)
0 (3)

100
ND
ND
ND
0 (2)
ND

Note: Control larvae were at late stage 3rd instar upon termination of the bioassay.
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4.2.3. Cytotoxicity Bioassay
Crude extracts containing PMAs were analyzed using a cell based bioassay to test
for cytotoxicity against 3 different cell lines; PC-3, SKMEL-5, and HEPG-2. Chloroform
extracts of APH, CAQS, and CMEX were used and the hexane extract of MC 81-11.
Cells were dried down and resuspended in 25µL of DMSO for a total concentration of
approximately 2% DMSO (maximum amount that the cells can withstand). No
bioactivity was observed in the cells using any of the cyanobacterial isolates as indicated
by the pink color from the alamar blue solution. The PMAs originally isolated showed no
bioactivity against cell lines (Mynderse and Moore, 1979) which was also similar to what
was observed for these cyanobacterial extracts containing crude mixtures of PMAs.

4.2.4. Antibacterial Bioassay
Five bacterial strains, including Gram-negative (E. coli) and Gram-positive, were
used to identify any potential antibacterial activity with the crude cyanobacterial extracts
known to contain the PMAs. Chloroform extracts were used for APH, CAQS, and
CMEX, and the hexane extract of MC 81-11 against the five strains of bacteria as shown
in the Table 4.2. Slight bioactivity was observed in the extracts from CAQS, CMEX, and
MC 81-11 against the bacteria B. megaterium and in the CAQS extract against E. coli,
however there was no other bioactivity observed against the other bacterial strains. No
bioactivity was observed for the APH against any of the bacterial strains. Since no
significant bioactivity was observed with any of the cyanobacterial isolates no further
fractionation was performed and no further analysis was carried out.

98

Table 4. 3: Antibacterial activity of extracts of the cyanobacterial isolates using 5 different strains
of bacteria.

Cyanobacterial
B. megaterium
Isolate
APH
CAQS
+
CMEX
+
MC 81-11
+

Bacterial Strain
B. subtilis E. coli
M. luteus
+
-

S. aureus
-

4.3. Methods
4.3.1. Zebrafish Maintenance and Breeding
The zebrafish (Danio rerio) embryo was used as a model of developmental toxicity
for both bioassay-guided fractionation and subsequent toxicological characterization. The
maintenance and breeding of adult zebrafish, and the embryo toxicity bioassays, were
carried out as previously described by Berry et al. (2004 and 2007) and according to
protocols approved by the FIU Institutional Animal Care and Use Committee (IACUC).
The zebrafish lines used for this experiment were obtained from Dr. Patrick Gibbs
(University of Miami Rosenstiel School of Marine and Atmospheric Science –RSMAS;
P4 line) and Petco Animal Supplies Inc. Adult zebrafish (males and females) were
maintained in tanks with dechlorinated tap water (treated with Amquel) at 26 ± 0.5oC on
a diet of fish flakes and brine shrimp. The zebrafish were subjected to a light/dark cycle
of 14h/10h with mating and spawning occurring at the beginning of the light cycle.
For breeding, about 10-20 male and female zebrafish were placed above a mesh
enclosure in a 10-L tank within 15 minutes of the onset of the light cycle. Upon
successful breeding, the fertilized eggs would fall through the mesh and settle at the
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bottom of the tank where they could be collected. After the eggs were collected, they
were rinsed fish water and subsequently placed in a Petri dish with E3 medium
containing methylene blue (5mM NaCl, 0.17mM KCl, 0.33mM CaCl2, and 0.33mM
MgSO4: Brand et al., 2002). Unfertilized and poor quality embryos were removed from
the dish and the remaining embryos were subsequently used (usually within 2-3 hpf) for
developmental toxicological studies.

4.3.2. Zebrafish Embryo Bioassay (Exposure Studies)
Toxicity was evaluated in solvent-resistant, polypropylene 24-well plates
(Evergreen Scientific, Los Angeles, CA) with five embryos per well in E3 medium
(Brand et al., 2002). Extracts and fractions were typically evaluated at a high- (100 μL)
and low- (10 μL) exposure concentration, and vehicle (corresponding solvent) and
“untreated” controls were also included in each assay. The solvent was evaporated from
the assay plates, prior to adding medium (E3) and embryos, and accordingly there was no
observed effect of the solvent (relative to the untreated controls). The embryos were
observed up to 5 days post fertilization (dpf) for bioactivity. In addition to percent
hatching and mortality, developmental toxicity was recorded by photomicrography using
an Olympus SZX7 stereomicroscope equipped with an Olympus DP72 digital camera.

Exposures with Individual PMAs: Purified PMAs were evaluated at concentrations
of 2, 5, 10, 25, 50 and 100 μg mL-1 (in acetonitrile). Vehicle (acetonitrile-only) and
“untreated” controls were also included with each exposure.
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Synergism Experiments: During purification of the PMAs, there was some evidence
to suggest that there was a synergistic relationship with the different PMAs which led to
the development of a synergistic experiment to analyze this possibility. Only PMAs 3 and
4 were obtained in sufficient quantities to do additional exposures and therefore were
initially used as a preliminary assessment of synergism at individual concentrations of 10,
25 and 50 μg mL-1 for a total concentration of 20, 50 and 100 μg mL-1 (for a total of 3
treatments).

4.3.3. Mosquito Larvicidal Bioassay
The mosquito larvicidal bioassay was performed by Jerry Berry using the following
protocol. Crude extracts and purified compounds were placed in 24-well polypropylene
plates and the solvent was allowed to evaporate. The plates were then filled with newly
hatched mosquito larvae (1st instar stage) in water using 4 larvae per well, for a total of
1mL. Solvent controls were prepared in the same manner as the cyanobacterial samples.
Larvae were fed daily with 30µL of a 0.1% yeast powder solution, and assessed for up to
8 days for mortality, current instar stage, and developmental effects.
Crude chloroform extracts of CAQS were tested at doses of 10, 50 and 100µL and
SPE fractions (40% hexane in ethyl acetate, 100% ethyl acetate, and 100% methanol)
using new eggs (approximately 2 weeks old). Purified PMAs (3-6) from CAQS were
used for the mosquito larvicidal bioassay at concentrations of 10, 25, and 50µg/mL for all
PMAs and up to 100µg/mL for PMA 4 only because it was the most abundant. Purified
samples were tested using both new (2 weeks) and old (2 months) eggs, representing the
wet and dry seasons respectively.
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4.3.4. Cytotoxicity Bioassay
The cytotoxicity bioassay was carried out using two different cancer cell lines
obtained from American Type Culture Collection (ATCC; Virginia, USA); prostate
cancer (PC-3), skin melanoma (SKMEL-5), and hepatoma (HEPG-6) cell lines. Cells
were sub-cultured using RPMI medium (for PC-3 and SKMEL-5) and Eagle’s medium
(for HEPG-6) in 96-well plates for bioassay. Exposures were carried out once the cells
were confluent. Prepared chloroform extracts containing a mixture of PMAs were tested
for cytotoxic activity at dosages of 0.25, 0.5, 1, and 2µL, using dimethylsulfoxide
(DMSO) as the solvent. Cells were incubated overnight after which the medium was
removed and replaced with 10% alamar blue in RPMI or Eagle’s medium for 4 hours to
assess for mortality. For dead cells, the medium will remain blue, and for live cells, the
medium will turns red/pink due to metabolism by the cells.

4.3.5. Antibacterial Bioassay
The antibacterial bioassay was carried out with five bacterial strains provided by
Miroslav Gantar (FIU, Department of Biological Sciences); Escherichia coli,
Staphylococcus aureus, Bacillus megaterium, Bacillus subtilis, and Micrococcus luteus.
Liquid cultures of the bacteria were prepared using nutrient broth for the bioassay.
Bioassays were done using the disc-diffusion method, using 6mm discs. Chloroform
extracts of APH and CAQS were applied to the discs (30µL) and the solvent was allowed
to evaporate before placing on the agar plate. Negative controls (solvent only) and
positive controls (neomycin at 0.1 and 0.5mg/mL) were also carried out. Liquid cultures
(approximately 1mL) were placed on the agar plates and dispersed for full coverage.
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Discs containing the samples and the controls were then placed on the plates which were
left to incubate overnight, and subsequently observed for inhibition of growth.

4.4. Conclusion
In the present study, the zebrafish embryo model was used to evaluate the
toxicological effects of a homologous series (Figure 2.1) of isotactic PMAs which are
toxic components of the lipophilic fraction of the Lake Kinneret isolate of A.
ovalisporum. Although, toxicological evaluation of these compounds was somewhat
limited by availability of purified amounts of the toxins - particularly given the relatively
low solubility/activity, and high exposure concentrations required, for the individual
congeners - our initial studies suggest both a dose-dependent toxicity relationship (Figure
4.2) and a relationship between toxicity in the zebrafish embryo model and structural
variations (i.e. chain length, degree of methoxylation) of the congeners. Moreover,
evaluation of the interactive effects indicates a possible synergism between variants with
enhanced developmental toxicity (Figure 4.3) observed for pair-wise combinations of the
PMAs (e.g. 3 and 4).
This is the first report of the PMAs as toxic or otherwise bioactive metabolites. It
is, accordingly, suggested that these metabolites may not only explain previously
observed developmental toxicity (Berry et al., 2009) of lipophilic fractions from A.
ovalisporum, but that these previously unrecognized (as toxic) components may
contribute to the overall toxicity of this CYN-producing bloom species, and the
cyanobacteria perhaps more generally. Indeed, the prior isolation of these compounds
(albeit as non-toxic metabolites) from other cyanobacterial species (Mynderse and
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Moore, 1979; Mori et al., 1991a and 1991b; Banker et al., 2000; Rao and Faulkner,
2002), and current identification of these compounds in additional strains of
cyanobacteria and also isolates of green algae suggests that these toxic metabolites are
relatively widespread, and not only within the cyanobacteria. As such, these compounds
contribute to the toxicity of cyanoHABs as well as green algal blooms.
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CHAPTER 5
BIOACTIVE CAROTENOIDS FROM CYLINDROSPERMOPSIS RACIBORSKII AQS
INHIBIT VERTEBRATE DEVELOPMENT IN ZEBRAFISH (DANIO RERIO)
EMBRYOS
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5.1. Introduction
Carotenoids are pigmented organic compounds which are found in many plants and
other photosynthetic microorganisms such as algae, fungi, and also cyanobacteria.
Carotenoids are generally thought to have two major roles in photosynthetic organisms;
light harvesting for photosynthesis (via the transfer to chlorophyll) and prevention of
photooxidative damage (Paerl, 1984; Hirschberg and Chamovitz, 1994). They can be
commonly found in the membranes, making up an integral part of the complex structure
of the membrane.
Many of the carotenoids are typically composed of a C-40 hydrocarbon backbone
(eight isoprenoid units), biosynthesized via the tail-to-tail attachment of two C-20
geranylgeranyl diphosphate molecules. Extension of this C-40 backbone can occur,
forming C-45 and C-50 carotenoids and the backbone can also be shortened, forming
apocarotenoids of various lengths. The hydrocarbon backbone can also be modified by 1)
cyclization of one of both ends of the molecule, 2) changes in the level of hydrogenation,
and 3) incorporation of oxygen into functional groups (reviewed by Britton, 1995). As
such, carotenoids can be divided into two classes; carotenes (which contain only
hydrogen and carbon) and xanthophylls (which contain hydrogen, carbon, and oxygen).
One of the most characteristic structural features of carotenoids is the long series of
conjugated double bonds along the polyene chain which gives rise to their light-absorbing
properties and hence their corresponding colors, which ranges from yellow to red. Each
double bond within the hydrocarbon chain of the carotenoid molecule can exist in the cis
or trans configuration, with the cis configuration being less thermodynamically stable
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due to steric hindrance between the methyl groups and the hydrogen atoms. In nature,
most carotenoids typically occur in the all-trans configuration (Britton, 1995).
Carotenoids, when isolated, are very unstable molecules that readily undergo
oxidation and isomerization when exposed to oxygen, heat, light, or acids after
extraction. It has been observed that carotenoids tend to undergo isomerization in extracts
containing chlorophyll and also when stored in acetone and exposed to light. In vivo,
carotenoids are much more stable than when isolated because they are stabilized by
proteins and other molecules. However if they come in contact with oxidizing species or
free radicals, they are still susceptible to oxidative damage in vivo, but to a considerably
lesser degree. Accordingly, great care must be taken during the extraction and isolation of
these compounds to prevent their decomposition. The most favorable conditions usually
involve working in dimly lit environments and keeping the samples dry and under inert
conditions.

5.1.1. Carotenoids from Cyanobacteria
Cyanobacteria are one of the oldest known photosynthetic organisms and are
therefore known to contain many pigments including chlorophyll, carotenoids, and other
accessory pigments which are involved in photosynthesis. In cyanobacteria, carotenoids
are found as major pigments in the thylakoid membrane, cytoplasmic membrane, and
outer membrane. They are commonly found as complexes with proteins. In the
thylakoids, they are bound to important membrane proteins that are a part of the reaction
center involved in photosynthesis, where they are involved in photoprotection (Vermaas
et al., 2008). In a Synechocystis sp. strain of cyanobacteria (PCC 6714), it was found that
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the carotenoids are found in the outer membrane of the cell wall with the more polar
carotenoids such as myxoxanthophyll, other carotenoid-glycosides and zeaxanthin are
major components of the cell wall, while the more non-polar carotenoids such as βcarotene and echinenone are the minor components (Jurgens and Weckesser, 1985). For
carotenoid-glycosides (specifically myxoxanthophyll), it was determined that one
molecule of carotenoid spans the one monolayer of outer membrane with the sugar
moiety acting as the polar head (Hirschberg and Chamovitz, 1994).
The carotenoids produced by cyanobacteria are thought to be the same as those
produced in plants with the exception of some xanthophylls that are unique to
cyanobacteria

such

as

2-hydroxy-derivatives,

ketocarotenoids,

and

glycosidic

carotenoids. Ketocarotenoids and glycosidic carotenoids are thought to be unique in
nature, especially within photosynthetic organisms (Britton et al., 2004). Figure 5.1
shows carotenoids that are commonly found in cyanobacteria include -carotene,
zeaxanthin, echinone, canthaxanthin, and myxoxanthophyll, with echinenone being found
only in cyanobacteria (Hirschberg and Chamovitz, 1994). Table 5.1 below lists the
different carotenoids that are found in cyanobacteria and the genera in which they have
been found.
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β-carotene

Zeaxanthin

Caloxanthin

Nostoxanthin

O

Echinenone

Canthaxanthin
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Myxoxanthophyll

Oscillaxanthin
Figure 5. 1: Chemical structures of some carotenoids commonly found in cyanobacteria.

There is a wide variation in the composition of carotenoids found in cyanobacteria
which may be due to the occurrence of the specific genes and pathways involved in the
biosynthesis of the carotenoids. It is well know that the composition of carotenoids within
the cyanobacteria is dependent on the growth conditions which includes growth stage,
light intensity, source and concentration of nitrogen in the cultures. It is also dependent
on the strain type within a given species (Takaichi and Mochimaru, 2007).
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Table 5. 1: Commonly occurring carotenoids in cyanobacteria with their maximum absorption (λmax) and spectral fine structure (%III/II)

Carotenoids
-carotene
-carotene

Astaxanthin

Caloxanthin
Canthaxanthin

-cryptoxanthin

Echinenone

Nostoxanthin
Oscillaxanthin

Cyanobacterial Genera
Chlorogloea, Oscillatoria
Anabaena, Aphanizomenon, Aphanothece, Arthrospira,
Calothrix, Chlorogloea, Coccochloris, Cylindrospermum,
Mastigocladus, Merimopedia, Microcoleus, Microcystis,
Nostoc, Oscillatoria, Phormidium, Spirulina,
Synechococcus, Tolypothrix
Anabaena, Aphanizomenon, Calothrix, Cylindrospermum,
Nostoc, Oscillatoria, Phormidium, Synechococcus,
Tolypothrix
Aphanothece, Arthrospira, Calothrix, Chlorogloea,
Nostoc, Phormidium, Synechococcus
Anabaena, Aphanizomenon, Calothrix, Chlorogloea,
Merimopedia, Microcystis, Nostoc, Oscillatoria,
Phormidium, Spirulina, Synechococcus, Tolypothrix
Anabaena, Aphanothece, Arthrospira, Chlorogloea,
Mastigocladus, Merimopedia, Microcystis, Oscillatoria,
Phormidium, Spirulina, Synechococcus
Anabaena, Aphanizomenon, Aphanothece, Arthrospira,
Calothrix, Chlorogloea, Coccochloris, Cylindrospermum,
Mastigocladus, Merimopedia, Microcoleus, Microcystis,
Nostoc, Oscillatoria, Phormidium, Spirulina,
Synechococcus, Tolypothrix
Aphanothece, Calothrix, Chlorogloea, Phormidium,
Nostoc, Synechococcus
Arthrospira, Chlorogloea, Microcystis, Oscillatoria
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λmax/nm (solventa)
439, 461, 491 (A)
429, 452, 478 (A)

# of CDB
11
11

%III/II (Sa)
40 (H), 35 (E)
25 (M)

480 (A)

13

single
spectrum

426, 449, 475 (E)

11

32 (M)

474 (E)

13

single
spectrum

428, 450, 478 (E)

10

25 (H)

460 (A)

12

single
spectrum

428, 450, 478 (E)

11

31 (M)

464, 491, 525 (M)

13

40 (M)

Zeaxanthin

Anabaena, Aphanizomenon, Aphanothece, Arthrospira,
Calothrix, Chlorogloea, Coccochloris, Cylindrospermum,
Mastigocladus, Merimopedia, Microcystis, Nostoc,
Oscillatoria, Phormidium, Spirulina, Synechococcus,
Tolypothrix
Myxol 2’Anabaena, Aphanizomenon, Aphanothece, Arthrospira,
glycoside
Calothrix, Chlorogloea, Coccochloris, Cylindrospermum,
(Myxoxanthophyll) Mastigocladus, Merimopedia, Microcoleus, Microcystis,
Nostoc, Oscillatoria, Phormidium, Spirulina,
Synechococcus, Tolypothrix
Aphanizophyll
Aphanizomenon, Microcystis, Oscillatoria, Anabaena
4-Keto-myxol-2’
Anabaena, Oscillatoria, Synechococcus
methylpentoside
a

Solvents: P- petroleum ether, H-hexane, E-ethyl acetate, A-acetone, M-methanol
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424, 449, 476 (P)

11

25 (P)

450, 478, 510 (A)
446, 472, 502, (M)

12

55(M), 57(A)

450, 476, 507 (A)

12

57 (A)

5.2. Results and Discussion
5.2.1. Isolation of the Carotenoids
The zebrafish embryo bioassay was used to guide the purification of two bioactive
compounds from the methanol fraction of C-AQS, both of which were pigments. The
10% methanol fraction obtained from the silica-gel column was subjected to RP-18 SPE
(Extract-CleanTM SPE C18-HC 10000 mg/75mL) with the bioactive fraction eluting in
95% methanol in water with the resulting fraction have a red color. Further purification
was done on the HPLC with a PDA detector (Prominence SPD M20A; scanning the
wavelengths from 200-700 nm) using an isocratic solvent system of 65% acetonitrile in
water, where the peaks were individually collected and tested on the zebrafish embryos.
The two peaks determined to be bioactive were observed at retention times of 6.68mins
(peak 1, which was red) and 8.59 mins (peak 2, which was orange) (Figure 5.2) and were
shown to cause inhibition of development in the zebrafish embryos. Other peaks were
identified in the fraction which seemed to be related to the bioactive peaks based on the
UV-vis spectrum; however no bioactivity (using the zebrafish embryos) was observed
with these peaks. Further analysis indicated that these peaks were the cis carotenoids
corresponding to the trans carotenoids isolated.
The bioactive peaks identified were individually collected and dried (under
vacuum) for chemical characterization. During the drying process, heat was applied to a
portion compound 1, which resulted in a loss of color to the sample, however the
remaining portion was dried without heat and these samples were kept separate.
Carotenoids are known to be very unstable and readily undergo decomposition when
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exposed to oxygen, heat, light, or acids after extraction. The typical indication for the
decomposition of the carotenoids is bleaching (loss of color). As such, it is thought that
the sample that was gently heated during the drying process underwent decomposition as
a result of its loss of color. It is therefore imperative to take the necessary precautions
during extraction and analysis of carotenoids to prevent the transformation of these
compounds.
a)
150

1

100
mAu

2

50

0
6.0

6.5

7.0

7.5

8.0

8.5

9.0

9.5

Minutes

b)

Figure 5. 2: a) HPLC Chromatogram of the bioactive fraction from the SPE cartridge showing the
two bioactive peaks at retention times of 6.68 mins (1) and 8.59 mins (2) and b) UV-Vis spectra
of the bioactive peaks from the chromatogram.
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5.2.2. Chemical Characterization of the Carotenoids from C. raciborskii AQS
The first steps in the identification of carotenoids usually involves the
chromatographic behavior and the UV-visible spectra which are distinctive for the
carotenoids present. The chromatographic behavior gives information about the polarity
of the carotenoids and the UV-vis absorption spectra gives important information about
the maximum absorption (max) and the spectral fine structure. The UV-vis spectra for
many carotenoids usually shows three distinct peaks with maximum absorptions (λmax)
between 420-520 nm which can be shifted depending on the number of conjugated
double bonds and conjugated cyclization within the structure. Substituents such as
hydroxyl groups, methoxy groups, non-conjugated rings, and non-conjugated carbonyl
groups have little or no effect on the λmax. This three-peak spectrum is highly indicative
of a carotenoid and can be used to assist in the determination of the number of conjugated
double bonds within the structure. The spectral fine structure (usually expressed as
%III/II) is an indication of the shape of the spectra which is also characteristic of the
chromophore and can be affected by the cyclization within the structure. The spectral fine
structure reaches its maximum when the number of conjugated double bonds (N) is eight
and decreases as it moves away from eight within the non-conjugated β-ring structure
(Takaichi and Shimada, 1992). The %III/II is calculated by diving the height of the
longest wavelength peak by the height of the middle wavelength peak (taking the
minimum between the two as the baseline) and multiplying by 100.
For peak 1, the max which was observed in 65% acetonitrile in water, was 321,
449sh, 480, and 509 nm which, in conjunction with the color of the compound (red),
indicates the possibility of the compound being a carotenoid. The three-peak spectrum
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observed was %III/II was determined to be 12% (Appnedix 5.1A), however this was
difficult to determine because the trough between the two peaks was very shallow. This is
usually indicative of a carotenoid with conjugated carbonyl group and in some case only
shows a single peak and the λmax is usually hard to determine (Takaichi and Shimada,
1992). For peak 2, the max which was also observed in 65% acetonitrile in water, was
295, 368, 450, 478, and 509 nm which, again with the color of the compound, also
suggested that the compound is a carotenoid. The three-peak spectrum for this compound
was 450, 478, and 509 nm from which the %III/II was determined to be 58% as shown in
Figure 5.3. Based on the %III/II and the max observed, these compounds were suggested
to be carotenoids, more specifically as derivatives of γ–carotene, which are well-known
to be produced by cyanobacteria (Hirschberg and Chamovitz, 1994).

II

III

200
100

296

mAu

300

508

8.60 Min
Lambda Max

200

477

0
300

400

500

600

700

nm
Figure 5. 3: Determination of the spectral fine structure (%III/II) for peak 2.

Mass spectrometric analysis (Figure 5.4) of the bioactive peak at retention time of
6.68 mins (1) from the HPLC showed m/z of 744.4 determined to be M+ peak and a m/z
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of 767.4 for the [M+Na]+ peaks. High resolution analysis gave an accurate mass of m/z
744.4548 corresponding to a molecular formula of C46H64O8 and having a ring and
double bond equivalent of 15 which correlates with the observed UV-Vis spectra. A
fragment peak was also identified at m/z of 581.4 giving a loss of m/z 163. The fragment
at m/z 581.4 could correspond to a myxol, which is a γ-carotene derivative, suggesting
that the loss of m/z 163 corresponds to a methylpentoside indicating that the suggested
carotenoid (m/z 744) is a myxol derivative with a glycosidic functional group.
Fragmentation of both the molecular ion peak and the fragmentation peak at m/z 581
(Appendix 5.1B) shows a sequential ladder loss of m/z 14 in the region with m/z below
300, which corresponds to the loss of methyl groups associated with carotenoids.
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a)
[M-163]+

00900 #4480-4681 RT: 10.34-10.80 AV: 51 NL: 3.41E8
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Figure 5. 4: ESIMS data of the purified bioactive compounds from in C. raciborskii showing the
molecular ion peaks and fragmentation peaks: a) Peak 1 with M+ peak of m/z 744.46 and
fragmentation peak of m/z 581.40 [M-163]+ and b) Peak 2 with M+ peak of m/z 730.48 and
fragmentation peak of m/z 567.42 [M-163]+.
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The second bioactive peak (2) that was isolated (tR 8.59 mins) and analyzed using
the LC-MS (low resolution), showed a m/z of 730.5 for the M+ peak and a m/z of 753.5
for the [M+Na]+ peak. Analysis using the HRESIMS gave a molecular ion peak of m/z
730.4801 corresponding to a molecular formula of C46H66O7 with a ring and double bond
equivalent of 14. A fragmentation peak was identified with a m/z 567.4 [M-163]+ which
again possibly corresponds to the presence of a methylpentoside. Fragmentation of both
the molecular ion peak and the fragment peak at m/z 567.4 showed a similar sequential
loss of m/z 14 (data not shown) to that of 1, which in conjunction with the UV-Vis
analysis, suggests that these compounds are carotenoids.

Peak 1 (m/z 744)

Peak 2 (m/z 730)
Figure 5. 5: Structure of 4-ketomyxol 2’-glycoside and myxol 2’-glycoside: the proposed
compounds for peaks 1 and 2 respectively.

Both compounds are thought to have a glycosidic functional group and based on
the MS fragmentation (loss of m/z 163) and previously identified glycosidic carotenoids,
suggest that the glycosidic group could be a methyl pentoside. The glycosidic group of
previously identified carotenoids with a methyl pentoside have been characterized as a
rhamnose or fucose, depending on the species from which they were identified (Takaichi
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et al., 2005). Determination of the glycosidic group for the currently isolated carotenoids
was not achieved due to the insufficient amounts of sample obtained and the constant
degradation of the compounds.

5.2.3. Bioactivity of the Carotenoids (Zebrafish Embryo Bioassay)
The zebrafish embryo bioassay was used to purify the bioactive compounds from
C. raciborskii, where a similar bioactivity was observed in the crude extract and each
subsequent bioactive fraction (Figure 5.6). Embryos were observed at 4dpf at which stage
normal untreated embryos should have hatched and the development of the body parts
and body axis is almost complete. Embryos exposed to extracts and fractions were
observed to not have development of the body axis as well as no distribution of the color,
with most of the color remaining in the head of the embryos. The embryos also did not
appear to have differentiation of the various body parts including the eyes, gills, and fins.
There was no hatching of the embryos up to 5dpf exposed to all treatments. There was
also no mortality observed as indicated by coagulated embryos however it was difficult to
ascertain a heartbeat due to the lack of complete development of the organs, especially
the heart.
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Figure 5. 6: Bioactivity of the extracts and fractions from C. raciborskii throughout the
fractionation process, showing the inhibition of development in the zebrafish embryos at 4dpf. A)
CHCl3 extract at 10µL, B) 10% MeOH fraction from glass column, C) 95% MeOH from RP-18
SPE cartridge.

The purified compounds were tested on the zebrafish embryos to confirm their
bioactivity. Compound 1 was tested at a range of concentrations; 1, 5, 10, 20 and 50
µg/mL with bioactivity observed only at 20 and 50 µg/mL (Figure 5.7A and B). Embryos
at the lower concentration (20µg/mL) showed partial development of the body parts such
as the eyes, however the body axis was slightly shortened and curved and there was
pericardial edema. At 5dpf, hatching of the embryos (n=5) was at 40% and there was
20% mortality observed. At the higher concentration (50µg/mL) the embryos showed
closer resemblance to the crude fractions with little or no differentiation of the eyes and a
shortened body axis. There was no hatching observed (0% hatching) up to 5dpf and also
no mortality observed. From the observations of the development of the embryos, it can
be seen that the higher concentrations showed greater inhibition of development of the
embryo and their hatching but there were no substantial effects on mortality up to 5dpf.
Embryos were not observed beyond this stage. For compound 2, the concentration tested
on the zebrafish embryos was unknown because it was tested directly from the HPLC,
however similar effects were observed as that of compound 1 at 5dpf (Figure 5.7C).
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The presumed decomposed sample of compound 1 was also tested on the zebrafish
embryos to determine if there was still bioactivity, however the tests were done at
unknown concentrations (10 and 100µL). No deformities were observed at the lower
dosage (10µL) but at the higher dosage (100µL), the embryos showed slight deformities
including bent tails and pericardial edema (Figure 5.7D). Additionally, there seemed to
be no effect on the hatching of the embryos at both dosages, with 100% hatching
observed at 5dpf.

Figure 5. 7: Bioactivity of the purified carotenoids from C. raciborskii showing the inhibition of
development in the zebrafish embryos at 3dpf. A) Peak 1 at 20µg/mL, B) Peak 1 at 50µg/mL, C)
Peak 2 (unknown concentration), D) Peak 1 (loss of color; unknown concentration), E) Retinoic
acid at 10nM, and F) Retinoic acid at 100nM.

Carotenoids undergo oxidative cleavage of the double bonds within the conjugated
system (See Figure 5.8) to form a class of aldehydes known as apocarotenals, including
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retinol, retinal, retinoic acid, and derivatives of each, such as 4-ketoretinoids. The most
well-known apocarotenal is retinal, a 20-C aldehyde which is formed from the cleavage
of the C15-C15’ double bond (Trautmann et al., 2013). Retinal is then converted to
retinoic acid in vertebrates by the enzyme retinal dehydrogenases. Retinoic acid acts as a
signaling molecule (morphogen) that produces specific cellular response based on the
concentration. These previously mentioned retinoids have been shown to cause
teratogenic effects in various organisms, including zebrafish embryos (Hermann, 1995),
mice (Nau, 1990), Xenopus larvae (Durston et al., 1989), and chicken embryo (Thaller
and Eichele, 1987). Zebrafish embryos were exposed to different concentrations of
retinoic acid and its analogues at 5 hours post fertilization (5hpf) after which they
observed various malformations including edema, brain deformities, and shortened and
bent tails (Herrmann, 1995 and Figure 5.7E and F). These malformations were similar to
those observed in the embryos exposed to the isolated carotenoids from CAQS (See
Figure 5.7).
It can therefore be proposed that the effects observed in the zebrafish embryos after
exposure to the glycosidic carotenoids could be due to the biotransformation into
apocarotenals or the corresponding retinoids, which have previously been shown to cause
malformations in fish and amphibians, and not necessarily the intact carotenoid.
Provitamin A carotenoids such as β-carotene have been extensively studied and shown to
undergo oxidative cleavage into retinoic acid and retinal. Non-provitamin A carotenoids
can also undergo oxidative cleavage into their corresponding retinoids and also other
metabolites, most of which are currently unknown (Nagao, 2004). Some of these
metabolites can be further metabolized under oxidative stress for elimination while the
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retinoid metabolites can interact with the same receptors as retinoic acid (Nagao, 2004;
Maden, 2002). Retinoids, including retinoic acid, are known to interact with retinoic acid
receptors (RAR) and retinoid X receptors (RXR) which then homodimerizes, binding to
the RA-response element (RARE) and subsequently activating the transcription of RA
target genes (Maden, 2002). Exposure of organisms to exogenous retinoids is known to
cause various malformations in vertebrates. The biotransformation of carotenoids could
lead to the increase in the amount of retinoids, which could be the cause of the inhibition
of development in the zebrafish embryos upon exposure to the carotenoids. A proposed
mechanism of action of the carotenoids in the zebrafish embryos is therefore via their
biotransformation into retinoids, causing an increase in the retinoids, which are known
teratogens.

Carotenoid
Biotransformation
Carotenoid 15,15’-oxygenase (CO)
RoDHs

Retinol

RALDHs

Retinal

Retinoic acid

Figure 5. 8: Reaction showing the biotransformation of carotenoids to retinoids by the cleavage of
the 15-15’ bond through the action of a carotenoid 15,15’-oxygenase to form retinal followed by
the conversion to retinol or retinoic acid by retinol dehydrogenases (RoDHs) or retinaldehyde
dehydrogenases (RALDHs) respectively.
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Furthermore, high incidences of malformations were observed in amphibians,
predominantly aquatic, from which various factors associated with these deformations
have been proposed (Gardiner et al., 2003). One such proposed factor is the occurrence
of teratogenic retinoids produced by cyanobacterial blooms, specifically a Microcystis
bloom in Lake Taihu, China (Wu et al., 2012 and 2013). Wu et al. (2012 and 2013)
identified high amounts of retinoids, namely retinoic acid, retinal, and 4-oxo-retinoic
acid, in the cyanobacterial species found in these lakes. A hypothesis can therefore be
made that carotenoids can undergo oxidative cleavage to form retinoids which can
contribute to the teratogenic effects associated with these blooms of cyanobacteria.

5.3. Methods
5.3.1. Bioassay-Guided Fractionation of the Bioactive Compound
A bioassay-guided fraction using the zebrafish embryo as the bioassay was
implemented for the isolation and purification of the bioactive compound from the strain
of C. raciborskii, C-AQS. The freeze-dried biomass was extracted twice in chloroform in
a ratio of 10:1 (mg:mL) after which the filtered extract was fractionated by normal-phase
flash-chromatography on a silica-gel glass column (Silica Gel 60Å, Commercial 40–63
μm). A stepwise gradient was used of ethyl acetate in hexane and then 10% methanol in
ethyl acetate. The zebrafish embryo bioassay was used to identify the bioactive fraction
(10% methanol in ethyl acetate), which was then further fractionated on a reverse-phase
solid phase extraction (RP-18, SPE) cartridge also with a stepwise gradient of methanol
in water. The bioactive fraction was observed to be the 95% methanol in water which was
further separated by reverse-phase HPLC (Phenomenex Luna 5 μm C5 100 Å LC
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Column 100 × 4.6 mm; isocratic 65:35 acetonitrile/water) with a PDA detector
(Prominence SPD M20A), wavelength range from 200-700nm). The zebrafish embryo
bioassay was then used to identify the two bioactive peaks at retention times of 6.68 and
8.59 minutes.

5.3.2. Characterization of bioactive compounds from C. raciborskii AQS
The purified compound was chemically characterized by UV-Vis analysis, and
mass spectrometry (low- and high-resolution). Analyses by mass spectrometry included
low-resolution analysis on a Thermo TSQ Quantum Access ESI/triple quadrupole
instrument coupled to a Thermo Accela UHPLC and high-resolution analyses on a
Thermo Orbitrap. Chemical characterization by NMR included one-dimensional
experiments (1H) and two-dimensional experiments (homonuclear: COSY) on a Bruker
AVANCE 400 MHz instrument.

4-ketomyxol 2’-glycoside (1): HRESIMS m/z 744.4548 (C46H64O8, [M]+, mmu of 2.24); RDB 15; UV/Vis 321, 449sh, 480, and 509 nm; %III/II 12

Myxol 2’-glycoside (2): HRESIMS m/z 730.4801 (C46H66O7, [M]+, mmu of -2.24);
RDB 14; UV/Vis 295, 368, 450, 478, and 509 nm; %III/II 58.

5.3.3. Zebrafish Embryo Bioassay (Exposure Studies)
The zebrafish (Danio rerio) embryo was used as a model of developmental
toxicity for both bioassay-guided fractionation and toxicity studies. Maintenance and
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breeding of adult zebrafish, and the toxicology studies with the embryos, were carried out
as previously described by Berry et al. (2007 and 2009) and according to the protocols
that were approved by the FIU Institutional Animal Care and Use Committee (IACUC).
All the toxicity studies were done in solvent-resistant, polypropylene 24-well plates
(Evergreen Scientific, Los Angeles, CA). Exposures were carried out using five embryos
per well in E3 medium (Brand et al., 2002). Extracts and fractions were typically
evaluated at a high- (100 μL) and low- (10 μL) exposure concentration; purified
compound 1 only was evaluated at 2, 5, 10, 20, and 50 μg/mL concentrations (in
methanol). Retinoic acid (obtained for Sigma Aldrich) was also tested at 10 and 100 nM
and the bioactivity was compared to that of the carotenoids. Solvent and “untreated”
controls were included in each assay; the solvent was evaporated from assay plates, prior
to adding medium and embryos, and accordingly there were no observed effects of the
solvent (relative to the untreated controls). The embryos were observed up to 5 days post
fertilization (dpf) for bioactivity which included mortality, inhibition of hatching, and
inhibition of development. In addition to percent hatching and mortality, developmental
toxicity was recorded by photomicrography using an Olympus SZX7 stereomicroscope
equipped with an Olympus DP72 digital camera.

5.4. Conclusion
The zebrafish embryos were used in the bioassay-guided isolation of two bioactive
glycosidic carotenoids. The occurrence of carotenoids in cyanobacteria has been well
documented and there is good evidence to suggest that they play a role in photosynthesis
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and also in the prevention of photooxidative damage. These identified glycosidic
carotenoids have been previously identified in other genera of cyanobacteria, including
Cylindrospermopsis. The sugar moiety of these carotenoids in Anabaena sp. and Nostoc
punctiforme was identified as fucose and not rhamnose (Takaichi et al., 2005), which
could be the same for these carotenoids identified from CAQS, however this remains to
be determined.
The bioactivities previously observed with these glycosidic carotenoids have been
related to photoprotection and antioxidant activity (Heydarizadeh et al., 2013). There
have not been any previous reports which shows these carotenoids to be toxic, however
from this study, it can be seen that these accessory pigments inhibit the development in
zebrafish embryos which was used as a model for vertebrate development. It could be
suggested that the cause of this bioactivity could be due to the decomposition of the
carotenoids into the corresponding retinoids which have been shown to be teratogenic in
zebrafish embryos and also amphibians. Further analysis is required to test this
hypothesis.
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CHAPTER 6
IDENTIFICATION OF LIPOPHILIC BIOACTIVE FRACTIONS IN THE OTHER
TOXIGENIC STRAINS OF FRESHWATER CYANOBACTERIA USING THE
ZEBRAFISH EMBRYO BIOASSAY
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6.1. Introduction
Cyanobacterial toxins were identified from 2 of the 4 isolates, proposed in this
project, namely APH and CAQS, however only partial purification was obtained with the
other two isolates, C. raciborskii 121-1 (denoted CMEX) and M. aeruginosa (denoted
MC 81-11). This chapter will therefore focus on the identification and partial purification
of the bioactive compounds/fractions identified from these two isolates.
M. aeruginosa 81-11 is a great lakes isolate that is known to produce microcystin.
C. raciborskii 121-1 (Mexico) was isolated from the Lake Catemaco, located in Vera
Cruz, Mexico where they have been seen to form large blooms year round. The toxins
CYN and paralytic shellfish toxins (PSTs), known to be produced by the genus
Cylindrospermopsis, have been shown to be present in this lake (Berry and Lind, 2010).
This lake represents one of the most productive fisheries in Mexico (Komarkova and
Tavera, 2003) and other studies have shown that there is bioaccumulation of these toxins
in tegogolo snails and finfish (Berry et al., 2012). With the importance of this fishery and
the prevalence of blooms of Cylindrospermopsis, this ecosystem provides a good
opportunity to study the effects of these known cyanobacterial toxins and unidentified
toxins on these aquatic species as well as the subsequent effects on human health.
Even though there were no bioactive compounds isolated from CMEX and MC 8111, multiple fractions from these lipophilic extracts showed bioactivity with there being
some indication to the nature of the compounds in a couple of these fractions. In addition
to the compounds that have been identified, there still remains many toxic metabolites
from these cyanoHABs that are unrelated to the known water-soluble toxins that
contribute to the toxicity of these species.
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6.2. Results & Discussion
6.2.1. Bioactive Fractions from C. raciborskii 121-1 (Mexico)
The extract was fractionated on a silica-gel glass column using a combination of
hexane, acetone, and methanol as the eluting solvents. A few sets of bioactive fractions
were observed from the silica-gel column eluting in 10, 15, 35% acetone in hexane,
100% acetone, and 100% methanol. The methanol fraction was subsequently analyzed
because of the observations from the zebrafish bioassay as well as the pigmentation of the
fraction.
The chromatogram of the 100% MeOH fraction (Figure 6.1) using the same
method as with CAQS, showed the bioactive peak (which was the main peak) to have a
retention time of 4.56 mins, indicating that this compound is slightly more polar than
those from CAQS. The UV-vis for the bioactive peak (denoted as 3) showed max of 451,
476, and 507nm with the %III/II of 56. A small sample was analyzed by Dr. Bill Louda
(Florida Atlantic University; Louda, 2008) with the sample eluting at 11.32 mins. The
max of the peak was 450, 476, and 508nm with the %III/II of 56. The sample was also
spiked with different standards of carotenoids (myxoxanthophyll and aphanizophyll;
obtained from DHI; Denmark) with the aphanizophyll standard eluting at the same
retention time as the main peak in the sample and having the same UV-vis spectrum
(Appendix A6.2). This data along with the UV-vis spectrum indicates that the main peak
is likely to be aphanizophyll (4-hydroxymyxol 2’-glycoside).
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Figure 6. 1: HPLC Chromatogram of the bioactive fraction indicating the bioactive peak at
4.56mins with the UV-vis spectrum.

Analysis of the fraction by HR-ESI-MS gave a molecular ion peak of m/z
746.4762 corresponding to a molecular formula of C46H66O8 with a ring and double bond
equivalent of 14 (Figure 6.2) . Another peak at m/z 769.5 corresponding to [M+Na]+,was
observed as well as a fragment ion at m/z 583.4 giving a loss of 163, which is thought to
be a glycosidic moiety such as a methylpentose as seen in the carotenoids from CAQS.
MS/MS analysis of the molecular ion gave a series of losses of m/z 14 was observed in
the region below m/z 200 which again is indicative of the presence of a long alkyl chain
(Appendix A6.1B).
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Figure 6. 2: HRESIMS of the bioactive peak with m/z 746.4762 corresponding to M+, 769.4654
for [M+Na]+, and the fragment ion at m/z 583.4152 [M-163]+, indicative of a loss of a methyl
glycoside.

Based on the data, the suggested structure of the compound is aphanizophyll
(Figure 6.3) which was originally identified in the cyanobacteria, Aphanizomenon flosaquae. This carotenoid have been previously identified in other strains of cyanobacteria;
M.

aeruginosa,

Oscillatoria

tenui,

Anabaena

aerulosa

oscillarotiaoides,

Thermosynechococcus elongatus, and C. raciborskii, however it has not been associated
with bioactivity (Stransky and Hager, 1970; Iwai et al., 2008; Mehnert et al., 2012).
Aphanizophyll was originally also called 4-hydroxymyxoxanthophyll (Hertzberg and
Liaaen-Jensen, 1971) but with later changes of myxoxanthophyll to myxol 2’-glycoside
(due to the different glycoside moieties present), it is now termed as 4-hydroxymyxol-2’glycoside. Further characterization by NMR is required to confirm the identity of this
compound and to determine the sugar moiety.
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Figure 6. 3: Structure of 4-hydroxymyxol glycoside (aphanizophyll) identified from the methanol
fractions of CMEX.

Due to the instability of carotenoids, especially during the extraction process (as
mentioned in Chapter 5), purification of the compound for further structural elucidation
was not accomplished. However, the above data strongly suggests that the bioactive
compound associated with this isolate of C. raciborskii is indeed 4-hydroxymyxol
glycoside.

6.2.2. Bioactive Fractions from M. aeruginosa
A solvent partitioning in hexane, acetone, and then chloroform showed the hexane
fraction as the only bioactive fraction and therefore hexane was used for all subsequent
extractions of the biomass. The hexane fraction was then tested at different doses from
which a clear dose-dependent relationship was observed (Figure 6.4) with 100%
mortality being observed at the highest dose (200µL) and inhibition of development at
sub-lethal doses down to 50µL. There was also a dose-dependent relationship observed
for the hatching of the embryos with 0% hatching at and above 100µL, 60% hatching at
50µL and 100% hatching in the controls. The hexane extract was subsequently
fractionated by two different methods to obtain the bioactive compound/s.
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Figure 6. 4: Graph showing the percent mortality and hatching of zebrafish embryos exposed to
different doses of MC 81-11 at 4dpf showing a clear dose-dependent relationship. The bioactivity
observed at 4dpf with the hexane extract of MC 81-11 at 50µL (A), 100µL (B), and an untreated
control (C).

Fractionation Method 1: The hexane extract was fractionated on a silica-gel
column with increasing amounts of ethyl acetate in hexane (5, 10, 15, 20, 25, 30, 35, 40,
and 50% ethyl acetate in hexane, and 100% ethyl acetate). With this solvent system, there
was a lot of streaking observed throughout the column and large sets of adjacent fractions
showed bioactivity suggesting that great separation of the compounds was not obtained.
The main set of bioactive fractions were collected from 15-30% ethyl acetate in hexane
and was pooled together for further separation on a prep-TLC. Five bands were observed
on the TLC with the first three bands showing bioactivity. These three bands were
subsequently run on the HPLC with fractions collected directly into the 24-well plate for
the bioassay with the bioactive regions shown in Figure 6.5. From the results of the
HPLC, there seems to still be overlapping of the bioactive peaks, with the same bioactive
region being observed in bands 1 and 2 (28-30mins) and also bands 2 and 3 (24-26mins).
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Figure 6. 5: HPLC Chromatogram of the bioactive regions collected from the TLC. Peaks were
collected at every 2 minutes in 24-well plates and tested for bioactivity. Bioactive peaks showed
no distinct UV spectra.

Mass spectral analysis was carried out to identify if the same masses were in the
different bioactive fractions which would suggested the possibility of the same bioactive
compound/s in the different bands. Table 6.3 shows the peaks with the same m/z and the
corresponding retention times. For TLC bands 1 and 2 with the bioactive fraction at 2830mins, there were no definitive peaks observed which showed similar masses between
the two bands. For TLC bands 2 and 3 with the bioactive fraction at 24-26mins there
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were 3 peaks observed in both fractions which showed the similar masses with similar
fragmentation patterns, however the retention times were slightly different. The three
peaks observed had decreasing masses of m/z of 44 with increasing retention times
suggesting that these compounds may be related.

Bioactive region
24-26mins

Table 6. 1: LCMS analysis of the bioactive fraction 24-26mins isolated from the HPLC showing
the similar m/z peaks observed and the corresponding retention times.

2nd band

rd

3 band

Retention
time /mins
15.37
16.23
17.07

493.09

476.91
432.98
388.90*

471.98*
427.98*
383.96

454.91
410.95
366.93

300.83
256.79
212.84

17.59
18.45
19.42

492.93
448.92
404.87

476.96*
432.93*
388.91*

471.99
427.99
383.95

454.89
410.95
366.93

300.79
256.80
212.85

m/z

*base peak

Fractionation Method 2: The hexane extract was fractionated on a silica-gel
column with increasing amounts of acetone in hexane (5, 10, 15, 20, 30, 40, and 50%
acetone in hexane, and 100% acetone) followed by a methanol flush. There were 11
fractions obtained from the silica-gel column of which three showed bioactivity in the
zebrafish embryos; 5% acetone in hexane, the second fraction from 10% acetone in
hexane, and 100% acetone. The 5% acetone in hexane fraction was run through another
silica gel column using hexane and ethyl acetate as the eluting solvents with two bands
observed using 5% ethyl acetate in hexane with the first band being bioactive. Further
purification was attempted with TLC and HPLC however there was not enough sample
remaining for subsequent bioassay-guided purification.
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Another column was repeated to collect more of the bioactive fraction eluting in 5
and 10% acetone in hexane. Further fractionation using the HPLC was carried out on
both fractions where fractions were collected every 2mins and subsequently tested on the
zebrafish embryos.
For the 5% acetone fraction, no bioactivity was observed within any of the
fractions. This could be due to the lipophilic nature of the compound and the bioactive
compounds were retained on the column with the method used. As such another column
was used and retested on the zebrafish embryos to identify any bioactive fractions. Figure
6.6 shows the chromatogram of the 5% acetone fraction indicating the two bioactive
regions (based on the zebrafish bioassay) and two different wavelengths at which these
compounds were observed.
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Figure 6. 6: HPLC Chromatogram of the 5% acetone in hexane fraction indicating the bioactive
regions (22-24mins and 26-28mins), observed at two different wavelengths.
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For the 10% acetone fraction, bioactivity was observed within 20-22mins and 2426mins (Figure 6.7), where all the embryos showed 100% mortality at 1dpf.
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Figure 6. 7: HPLC Chromatogram of the 2nd band in the 10% acetone in hexane bioactive
fractions at 20-22mins and 24-26mins.

6.3.Methods
6.3.1. Bioactive fractions from C. raciborskii (Mexico)
Freeze-dried biomass was weighed and extracted in chloroform and sonicated. The
extract was run through a silica-gel glass column using hexane, acetone, and methanol as
the eluting solvents using the following solvent system; 10, 15, 20, 25, 30, 35, 40, and
50% acetone in hexane, 100% acetone, and 100% methanol. The methanol fraction had
pigments similar to those observed in CAQS and was therefore analyzed for the presence
of carotenoids using HPLC-PDA and HRESIMS.
Analysis of the pigments was carried out by William Louda (FAU) according to the
method by Louda (2008). Separation was done using reverse-phase HPLC using a Waters
NovaPak 4µ C18 column (3.9 x 150mm) coupled to a photodiode array detector (PDA)
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for identification of the pigments. The HPLC solvent system implemented involved three
solvent systems over a 48-minute period as shown in Table 6.4.
Table 6. 2: HPLC-PDA method used to separate and identify the carotenoids present in the
methanol fraction of CMEX.

Time (minutes)
0
5
10
40
45
46
47
48

Solvent “A”
60
60
0
0
0
0
0
60

Solvent “B”
40
40
100
30
30
0
100
40

Solvent “C”
0
0
0
70
70
100
0
0

Solvents: A – 0.5M ammonium acetate in methanol/water (85:15, v/v), B – acetonitrile/water
(90:10, v/v), C – ethyl acetate.

4-hydroxymyxol glycoside (aphanizophyll): HRESIMS m/z 746.4762 (C46H66O8, [M]+,
mmu of 0.850) with a ring and double bond equivalent of 14.0.

6.3.2. Purification of Bioactive Compounds from M. aeruginosa
Fractionation Method 1: The biomass was extracted in chloroform. The extract
was dried down and solvent partitioned in hexane, acetone, and chloroform. The only
bioactive fraction was hexane; therefore further extractions were done with hexane. The
hexane extract was fractionated on a silica-gel glass column with increasing percentages
of ethyl acetate in hexane (0, 5, 10, 15, 20, 25, 30, 40, 50, 100% ethyl acetate).
Bioactivity was observed in fractions within the solvent systems 10-30% ethyl acetate in
hexane. These fractions were then pooled together and a preparative-TLC was done with
the solvent system of 15% ethyl acetate, 3.75% isopropanol, 81.25% hexane (8.1:1.5:0.4
- Hexane:Ethyl acetate:Isopropanol). From the preparative-TLC, 8 different regions were
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collected; 6 distinct bands plus the top and bottom of the TLC plate. Bioactivity was
observed in bands 1-3 (100% mortality) and 5-6 (all embryos deformed) of the zebrafish
embryos within 24hpf and as such the first 3 bands were collected and ran through the
HPLC [Method: Phenomenex Luna 5u C-18 Analytical Column: Acetonitrile and water
gradient starting with 50% acetonitrile for 5mins then increase to 100% over 20mins,
kept at 100% acetonitrile for 15mins, then back to 50% acetonitrile over 5mins for a total
of 40mins]. Fractions were collected from the HPLC at 2 minute increments and the
bioactive bands observed were analyzed on the LCMS in an attempt to identify masses
within the fractions.

Fractionation Method 2: This hexane extract was then fractionated using a silicagel glass column with increasing amounts of acetone in hexane (0(1), 5(1), 10(2), 15(1),
20(2), 30(1), 50(1), 100% (1) acetone) then flushed with 100% (1) methanol for a total of
11 fractions. The 5% acetone in hexane bioactive fraction was solvent partitioned in
methanol and then hexane, with the methanol fraction showing bioactivity. The methanol
fraction was further subjected to a lipophilic-sephadex (LH-20) column, using methanol
as the mobile phase solvent where no further separation was observed. Additional
purification attempts were carried out to identify the bioactive compound/s using TLC
and HPLC-UV, however no further bioactivity was observed with the subsequent
fractionation steps, more likely as a result of insufficient sample. Additional biomass was
obtained, extracted in hexane, and fractionated as before using the same column with
hexane and acetone as the eluting solvents. The two bioactive fractions were then run on
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the HPLC and fractions collected every two minutes in 24-well polypropylene plates to
test on the zebrafish embryos.

6.4.

Conclusion
The zebrafish embryo model was used as a bioassay to identify bioactive

compounds within the lipophilic extracts of known toxigenic cyanoHAB species. Two
sets of bioactive compounds were identified from two of these species (APH and CAQS)
however there were additional isolates (CMEX and MC 81-11) in which bioactivity was
observed, however only bioactive fractions containing more than one compounds were
determined. Progress however was made towards the determination of the bioactive
metabolite/s from both of these isolates. The isolate CMEX was shown to produce the
carotenoid, aphanizophyll, a known carotenoid produced by cyanobacteria. This
carotenoid as with others is associated with photoprotection however crude extracts
containing aphanizophyll caused developmental malformations in zebrafish embryos.
The lake in which this isolate of cyanobacteria is found is well known for its fisheries and
the occurrence of these toxic metabolites may greatly affect the production of some fish
species. MC 81-11 has also shown various fractions which are bioactive, causing
mortality as well as inhibition of development in the zebrafish embryos. Further
purification is needed to identify the bioactive compounds from these fractions.
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7.1. Occurrence of Bioactive Lipophilic Secondary Metabolites
Cyanobacteria are known to produce a wide array of secondary metabolites, which
when negatively associated with health effects, are termed toxins. It is still unclear the
purpose of these cyanobacterial toxins, however it is known that there are additional
bioactive compounds, different from the known cyanotoxins, within the lipophilic
extracts of these cyanobacterial HABs that contribute to the toxicity of the strains. Within
this project, we have identified and purified two sets of bioactive compounds, which
although previously identified, have not been associated with negative health effects.
Through the use of the zebrafish embryo assay as a model for vertebrate development, we
were able to identify these compounds as bioactive lipophilic secondary metabolites and
gain a better understanding of the bioactivity associated with these compounds.
PMAs have been identified over three decades ago and were identified based on
their structure. There was no bioactivity observed with the PMAs according to traditional
bioassays (such as the cytotoxicity assay) with this being the first reported bioactivity
associated with these compounds. Identified from these strains were six variants of the
PMAs, differing from each other by the number of methoxy groups present, with the
methoxy groups ranging from seven to twelve. As previously mentioned, these
compounds were previously identified in other genera of cyanobacteria suggesting that
they may be widespread in nature. Analysis of a culture collection provided by Miroslav
Gantar (FIU, Department of Biological Sciences), indicated that these metabolites are
relatively widespread and can be found in a number of genera of cyanobacteria belonging
to different orders, as well as different genera of green algae. The structure of the PMAs
suggests that the biosynthesis may involve the PKS biosynthetic pathway and based on
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the feeding experiments done with 13C-labeled acetate, this hypothesis seems to hold true.
However, NMR analysis indicates that the pattern of incorporation does not follow that of
a PKS biosynthetic route and suggests that the biosynthesis may occur via a different
pathway. Evaluation of the bioactivity using the zebrafish embryos indicated a possible
structure dependence on the bioactivity with the bioactivity decreasing with the
increasing size of the molecules. This difference in bioactivity could also be related to the
solubility of the compounds since the medium for the bioassay is water and the PMAs are
lipophilic.
Carotenoids were the second set of compounds identified to inhibit the
development in zebrafish embryos. Characterization by NMR was difficult due to the
insufficient quantities obtained for each of the compounds as a results of their instability,
however other tools were used to identify the nature of these compounds. Carotenoids are
known to be primary metabolites, preventing against photooxidation and aiding in
photosynthesis. Additionally, they have been largely used as antioxidants in humans and
other animals. However, the glycosidic carotenoids identified from the two strains of C.
raciborskii inhibits development of the zebrafish embryos, which is the first report of
negative effects associated with these compounds. A possible mechanism of bioactivity
could be the decomposition of the carotenoids to retinoids which have been shown to
cause malformations in zebrafish embryos, amphibians, and chicks. Further biological
characterization of these compounds are necessary to identify their mode of action.
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Table 7. 1: Cyanobacteria and green algae chloroform extracts that were used in the screening
against the zebrafish embryos, indicating the ones that showed bioactivity by inhibiting their
development and were also shown to produce PMAs, carotenoids, or both.

Isolates
Cyanobacteria
*Aphanothece 103-7
*Aphanizomenon APH
C. raciborskii 121-1
C. raciborskii AQS
*Microcystis 81-11
Pseudanabaena 108-1
Green Algae
Chlamydomonas 80-1
Kirchneriella 104-7
Scenedesmus 79-1
Scenedesmus 80-15

PMAs

Carotenoids

X
X
X
X

X
X

X
X

*Previously identified genera to produce myxoxanthophyll and other currently identified
bioactive carotenoids.

Table 7.1 shows the cyanobacterial and green algal isolates that were shown to
inhibit development in zebrafish embryos. From the screening of the PMAs, four of the
cyanobacterial isolates and two of the green algal isolates produced one or more of the
PMAs identified within this study. Bioactive glycosidic carotenoids were identified in
two of the cyanobacterial isolates in this study while three of the other genera, namely
Aphanothece, Aphanizomenon, and Microcystis are known to also produce glycosidic
carotenoids, specifically myxol 2’-glycoside and 4-ketomyxol 2’-glycoside. The
bioactivity associated with the lipophilic extracts of these isolates could be related to the
presence of these bioactive compounds, namely PMAs, carotenoids, or both. There are
also other compounds, other than the ones identified in this project, within these isolates
that are responsible for the bioactivity observed which gives rise to the toxicity of the
strain.
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In addition to the identified bioactive compounds within this project, there still
remains a whole suite of toxic secondary metabolites from these cyanoHABs that are
unrelated to the known water-soluble toxins that may contribute to the toxicity of these
HAB species. This may pose a great health risk to animals and humans due to the
frequent occurrence of these cyanoHAB species and the possible bioaccumulation of
these compounds in the food chain.

7.2. Zebrafish Embryos as a Model for Vertebrate Development
The zebrafish embryo was used in this project as a model for vertebrate
development in the identification, purification, and characterization of lipophilic
secondary metabolites from freshwater isolates of cyanobacterial HABs. The lipophilic
extracts of these HAB species were previously identified to show that they contained
bioactive compounds that inhibit the development in zebrafish embryos. Further
evaluation of these extracts using the zebrafish embryo bioassay to guide the
fractionation led to the purification of the previously mentioned bioactive compounds.
Due to the advantages of this model, it allowed for the rapid and high-throughput analysis
in bioassay-guided purifications of bioactive metabolites from various sources, including
cyanobacteria.
The zebrafish embryo has also been well used as a toxicological model in
evaluating the effects of the known cyanotoxins on the development. We were also able
to use them in the analysis of the chemically characterized lipophilic metabolites isolated
from the cyanobacteria to further understand their effects on vertebrate development. The
zebrafish embryo model has therefore proven to be a well-suited model for the
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identification of bioactive compounds as well as the study of known and unknown
cyanobacterial toxins.

7.3. Future Directions
Cyanobacterial HABs are a continuous problem in today’s environment due to the
effects of climate change and the eutrophication of the water sources which are
conducive for the growth and persistence of these blooms. As such, continued research is
required in the identification of the novel metabolites produced by these blooms that will
contribute to their toxicity as well as a better understanding for the known metabolites
produced during these blooms events. This project was able to identify a new set of
previously identified compounds not associated with bioactivity (PMAs), as well as a set
of bioactive compounds that have only be associated with its beneficial effects
(carotenoids). However, we know that there is still a suite of compounds that have not
been identified as indicated from the bioactive fractions from the other cyanobacterial
strains (C. raciborskii 121-1 and M. aeruginosa) both of which are highly recognized as
HABs. Final purification and subsequently chemical characterization is required to
identify these not yet identified compounds from the aforementioned cyanoHABs,
especially due to the fact that these genera are recurrent HAB blooms in freshwater
sources around the world. The Mexico strain of C. raciborskii is in constant bloom and
therefore provides us with a great opportunity for the study of metabolites from this
species and the impact the blooms have on the environment, including the aquatic life,
and human and animal health.
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These cyanoHABs produce a wide variety of compounds with different effects on
organisms. It is understood how some of these compounds affect the organisms but these
compounds are not produced individually. As such, it would be interesting to analyze the
combined effects of these compounds produced by each isolate on the toxicity of
organisms to assess the possibility of a synergistic effect or maybe even a protective
effect of one or more of these compounds. This would help to understand the overall
toxic effects associated with these blooms and not just the effects from the individual
components, which would allow for better management of water sources during the times
of these blooms.
Carotenoids are known for the beneficial impacts in cyanobacteria and in other
organisms however, we now know that these molecules also have negative impacts,
inhibiting the development of zebrafish embryos and possible other vertebrate species. It
would therefore be important to be able to identify the different carotenoids produced by
the different cyanobacterial species both in culture and in nature, and the bioactivity, if
any, associated with them. Further investigation is required for the understanding of the
mechanism of action of these carotenoids and to test the hypothesis of the
biotransformation of the carotenoids into retinoids, specifically identifying which types
of retinoids are formed from the different carotenoids. Also, it is known that different
carotenoids are produced at different temperatures and with the changes in the climate,
knowledge of the toxicity of the carotenoids produced at different temperatures will also
help to understand the toxicity of these blooms.
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APPENDICES
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A2.1. PMAs Isolated from A. ovalisporum
A2.1.1. PMA 1 1H-NMR in C6D6

A2.1.2. PMA 2 1H-NMR in C6D6

A2.1.3 - PMA 3 1H-NMR in C6D6
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A2.1.4. PMA 4 1H-NMR in C6D6

A2.1.5. PMA 5 1H-NMR in C6D6
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A2.1.6. PMA 6 1H-NMR in C6D6

A2.1.7. Blank (NMR tube for PMA 4)

Note: Benzene blank with the same tube used for PMA 4 indicating the presence of
impurities associated with the NMR tube.
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A2.2. PMAs Isolated from C. raciborskii
A2.2.1. PMA 2 1H-NMR in C6D6

A2.2.2. PMA 3 1H-NMR in C6D6

C – DEPT-135
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D - COSY
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A2.2.3. PMA 4 1H-NMR in C6D6

A2.2.4. PMA 5 1H-NMR in C6D6
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A2.3. Mass Spectral Data for PMAs from A. ovalisporum
A2.3.1. MS of PMA 1
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A5.1. CAQS Carotenoid 1 (m/z 744)
A) UV-Vis spectrum from the HPLC-PDA run isocratically at 65% acetonitrile in water.
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B) MS/MS of Carotenoid 1 (Molecular ion peak m/z 744)
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A6.1. CMEX Carotenoid 3 (m/z 746)
A) HPLC-UV/Vis spectrum of the bioactive peak from the 100% MeOH fraction. The
solvent system used for the HPLC run was 65% acetonitrile in water (isocratic).
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B) MS/MS of the bioactive peak (m/z 746)
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A6.2. CMEX (Carotenoid 3; Louda method)
A) Total chromatogram of methanol fraction from CMEX which the proposed
aphanizophyll peak at 11.32mins circled.

B) UV-spectrum of the proposed aphanizophyll peak at 11.32mins [UV-vis: 451, 476,
507nm, %III/II 56]
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A6.3. MC 81-11 (LC-MS of bioactive fractions from TLC band 2 and 3, 24-26mins)
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